



E. F. Pfeiffer, Ulm 
J . E. Ral l , Bethesda 
Assistant-Editors: 
W. D. Hetzel , Ulm 
B. Weintraub, Bethesda 
384 Figures 
in 485 Single figures 






TABLE OF CONTENTS 
No. 1 (January 1979) page 1 84 No. 7 (July 1979) page 4 1 5 - 4 5 4 
No. 2 (February 1979) page 85 186 No. 8 (August 1979) page 455 492 
No. 3 (March 1979) page 187 260 No. 9 (September 1979) page 493 532 
No. 4 (Apri l 1979) page 261 - 322 No. 10 (October 1979) page 533 - 588 
No. 5 (May 1979) page 323 378 No. 11 (November 1979) page 589 646 
No. 6 (June 1979) page 379 414 No. 12 (Decembcr 1979) page 647- 700 
Wicklmayr, M., G. Dietze Darwish, S.A.E., B.L. Furman 
Effect of Metaproterenol on Ketone Body Effects of Levodopa and Doapmine on Plasma 
Metabolism of the Forearm in Healthy and 11-Hydroxycorticosteroid Concentrations in 
Diabetic Subjects 1 Mice 44 
Rath, R., K. Vondra, A. Bass, J. Teisinger, Radö, J.P., T. Simatupang, P. Roer, E.J. Dor-
is vitek hout Mees 
Energy Metabolism Enzymes in Adipose Tissue Increase of Serum Potassium in the Upright 
and in Muscle in Obesity 6 Posture in Selective Hypoaldosteronism 47 
Lombardo, Y.B., I.A. Meimhan wood, W.G., B.J. Britton, M.H. Irving 
Gluconeogenesis in Perfused Livers of Geneti- Effects of Adrenergic Blockade on Plasma Cate-
cally Obese-Hyperglycemic (ob/ob) Mice . . . . 9 cholamine Levels Düring Adrenaline Infusion . 52 
Kukulansky, T., G. Yagil Barlet, J.-R, M.-J. Davicco, J. Lefaivre, B.J. Car-
On the Effect of Insulin on Glucose-6-Phosphate n " ° 
Dehydrogenase and Fatty A c i d Synthetase Ac t i - F e t a l B l o o d Calcium Response to Maternal Hy-
vity in Mouse Liver 14 percalcemia Induced in the Cow by Calcium In-
n , „ „ , r _ , „ ^ „ , fusion or by Solanum Glaucophyllum Ingestion 57 OConnor, RA., J.M. Conlon, K.D. Buchanan, 
R.F. Murphy Maurer, W., W. Braendle 
The Use of Perfused Rat Intestine to Character- Evidence for Different Forms of Human Cho-
ise the Glucagon-Like Immunoreactivity Released r i o n i c Gonadotropin Receptor Compiex in 
into Serosal Secretions Following Stimulation by Pseudopregnant Rat Ovaries 1 ^ 60 
Glucose 19 Lakshmaiah, N., M.S. Bamji 
Taniguchi, II, M. Hasegawa, T. Kobayashi, Y. Effect of Oral Contraceptives on Folate Econo-
Watanabe, M. Murakami, M. Seki, A. Tsutou, ™y a Study in Female Rats 64 
M. Utsumi, H. Makimura, M. Sakoda, S. Baba Morley, J.E., I.A. Distiller, S. Epstein, M. Katz, 
Enhancement of Leucine-Induced Insulin Se- c Q0fd j Sagei # Xaye, M. Pokroy, J. Kalk 
cretion by Somatostatin Antiserum Pretreat- Menstrual Disturbances in Chronic Renal 
ment 23 Failure 68 
Kubek, M.J., J.F. Wilber, JE. Leesthma Hollo, I, L. Gero, F. Szalay, L. Koranyi, K. 
The Identification of Gonadotropin-Releasing Steczek 
Hormone (GnRH) in Hypothalamic and Extra- Insulin-, Glucagon- and Calcitonin-Induced 
hypothalamic Loc i of the Human Nervous Early Decrease in Serum Calcium 72 
S y S t e m 2 6 Owens, D.R., K.G. Wragg, K.J. Shetty, PI. Biggs, 
May, R, J. Mittler, A. Manougian, N. Ertel c.D. Davies 
T S H Release-Inhibiting Act ivi ty of Leucine- A c u t e and Chronic Effect of Chlorpropamide 
Enkephalin 30 j n M . O . Diabetes 77 
Faber, /., T. Friis, C. Kirkegaard, I.B. Lumholtz, Macnab, M., R.B. Goldberg, B.I. Joffe, A. Botha, 
J. Mcjikholm-Hansen, K. Siersbaek-Nielsen, L. // £ Seftel 
Skovsted, P. Theilade Carnitine and Experimental Ketotic and Non-
Serum T 4 , T 3 and Reverse T , Düring Treatment Ketotic Diabetic Stupor 78 
with Propranolol in Hyperthyroidism, L - T 4 _ _ „ , . _ _. 
t „ T „ A \ \ A A • K i i \i TA Shapiro, B., S. Kronheim, ß. Pimstone 
Treated Myxedema and in Normal Man 34 _ , K „ ' ' . , _ 
The Presence ot Immunoreactive Somatostatin 
Mobley, P.W., PU. Dubuc m R a t Retina 79 
Thyroid Hormone Levels in the Developins „ . _ _ . 
t j , i C A m Giannetto, B.O., M.D. Griswold 
Obese-Hyperglycemic Syndrome 37 ' , ' , ,« ,. 
Hormone-Supplemented Medium Enhances A n -
Sorimachi, K., J. Robbins drogen Binding Protein Secretion in Sertoli 
Effects of Propylthiouracil and Methylmercap- Qe\[ Cultures 80 
toimidazol on Metabolism of Thyroid Hormones 
by Cultured Monkey Hepatocarcinoma Cells . . 39 
IV Table of Contents 
Garmendia, F., E. Urdanivia, E. Kesserü 
Carbohydrate Metabolism in Women Receiving 
d-Norgestrel for Postcoital Contraception . . . 81 
Havelka, S., A. Babicky, J. Musilovd, D. Roholko-
va, B. Tesärek 
Effect of Osteotropic Hormones on Cartilage 
Metabolism 83 
Congress-Announcements 84 
Hansen, B., S. Linde, K. Halendorf, F. Jensen 
Absorption of Protamine4nsulin in Diabetic 
Patients I.Preparation and Characterization 
of Protamine- 1 2 5 Hnsu l in 85 
Jacoby, J.H., G.F. Bryce 
The Acute Effects of 5HTP. Fluoxetine and 
Quipazine on Insulin and Glucagon Release 
in the Intact Rat 90 
Loubatieres-Mariani, MM., R. Alric, J.P. Blayac, 
G. Valette 
Is Lactate Involved in Phenformin-Induced 
Insulin Secretion? 95 
Pontiroli, A.E., P. Micossi, P.P. Foä 
Effects of Histamine, of Histadine and of A n t i -
Histaminic Agents on the Release of Glucagon 
and Insulin from the Rat Pancreas 100 
Joost, H.G. 
Effects of a Possible Beta-Cell Membrane Label, 
Metahexamide-lsothiocyanate, on Insulin Re-
lease 104 
Guzdek, A., M. Sarnecka-Keller, A. Dubin 
The Activities of Perfused Livers of Control 
and Streptozotocin Diabetic Rats in the Syn-
thesis of Some Plasma Proteins and Peptides . 107 
Honey, R.N., S. Price 
The Determinants of Insulin Extraction in the 
Isolated Perfused Rat Liver 111 
Kalopissis, A.D., A. Girard, S. Griglio 
Diurnal Variations of Plasma Lipoproteins and 
Liver Lipids in Rats Fed Starch Sucrose or Fat 118 
Sitbon, G., P. Mialhe 
Pancreatic Hormones and Plasma Glucose: 
Regulation Mechanisms in the Goose under 
Physiological Conditions. IV-Effects of Food 
Ingestion and Fasting on Pancreatic Hormones 
and Gut GLI 123 
Schleiffer, R., C. Mialhe, B. Briaud, B. Lutz-
Bucher, B. Koch 
Effects of Adrenalectomy and Hypercorticism 
on the A C T H Content of the Anterior and 
the Posterior Pituitary in Rats with Inherited 
Diabetes Insipidus (Brattleboro Strain) 130 
Birnbaum, R.S., HM. Goodman 
Comparison of Several Insulin-Like Effects 
of Growth Hormone 136 
Livesey, JH., R.S. Scott, R.A. Donald 
Urinary Growth Hormone in Diabetic Keto-
acidosis 142 
Sara, V.R., R. Rutherford, G.A. Smythe 
The Influence of Maternal Somatostatin Ad-
ministration on Fetal Brain Cell Proliferation 
and its Relationship to Serum Growth Hor-
mone and Brain Trophin Act iv i ty 147 
Fräser, WM., H.St. Tucker, SR. Grubb, J.P. 
Wigand, W.G. Blackard 
Effect of L-Tryptophan on Growth Hormone 
and Prolactin Release in Normal Volunteers 
and Patients with Secretory Pituitary Tumors 149 
Curbelo, HM., E.C. Karliner, A.B. Houssay 
Effect of Acute Hypoxia on Blood T S H Levels 155 
Hartmann, F., F. Jentzen 
Effect of Chlorphentermine on Hormone Con-
tent and Function of the Adrenal Cortex in 
Rats 158 
Calvo, J.C., L. Biella de Souza Valle, J.L. 
Baranao, M. Tesone, E.H. Charreau 
N A D P H Generating Enzymes in Leydig Cells 
from Diabetic Rats 161 
Puett, D., R. Benveniste, A. Kenner, D. Rabi-
nowitz 
The Carbohydrate Moiety of Human Chorio-
nic Gonadotropin: Lack of Competition with 
H C G for Testicular Receptors and Ant i -HCG-
Serum 165 
Haas, H.G., M.A. Dambacher, J. Guncaga, 
T. Lauffenburger, B. Lämmle, J. Olah 
1,25 ( O H ) 2 Vitamin D 3 in Osteoporosis 
A Pilot Study 168 
Hayek, A., C. Kuehn 
Adrenalectomy Does not Prevent Ketoacidosis 
in Streptozotocin-Diabetic Rats 172 
Palmieri, G.M.A., J. Hawrylko 
Enhancement by Propranolol of the Insulin 
Induced Hypoglycemia in the Chick 173 
Cohen, R., J.P. Luzio 
Hormonal Effects on [ 3 H ] Leucine Incorpora-
tion into Rat Adipocyte Plasma Membrane . 174 
Kather, H., R. Mordasini, P. Oster, G. Schlierf 
B. Simon 
Synergistic Effects of Adrenaline and Prosta-
glandin E] on the Human Fat Cell Adenylate 
Cyclase 176 
Le Roith, D., H. Bark, SM. Glick 
Somatostatin and Antidiuretic Hormone Secre-
t ion in Dogs 177 
Hainer, V, L. Krejöik, L. Stark, J. Urbdnek 
Glucagon-Induced Fall of Serum Cortisol 
Levels: Effect of Cyproheptadine Pretreat-
ment 178 
Table of Contents V 
Follenius, M., G. Brandenberger, M. Simeoni, 
B. Reinhardt 
Plasma Aldosterone, Prolactin and A C T H : Re-
lationships in Man during Heat Exposure . . 180 
Doerr. P. 
Relationship between Saturation of L H Recep-
tors and Steroidogenic Response in Isolated 
Rat Granulosa Cells 181 
Sobrino, F., E. Pintado, J.C. Prieto, G. Ruiz, 
R. Goberna 
Plasma-cAMP Concentration in Fasting Rats. . 183 
Yamada, Y., S. Ito, R. Kayamori, A. Shibata 
The Effects of Vitamin D 2 on the Somatosta-
tin and Calcitonin Concentration in the Rat 
Thyroid 184 
Congress-Announcements 186 
Kansal, P.C., M.S. Bandisode, B.R. Boshell 
Determination of Insulin Antibodies 187 
Renauld, A., R.C., R.C. Sverdlik, R.R. Rodri-
guez 
Actions of Aminophylline on the Blood Sugar, 
Serum Insulin and Serum-free Fatty Acid Re-
sponses to Glucose in Hyperthyroid Dogs . . 190 
Tober, C, U. Krause, J. Beyer, L. Herberg 
Studies with Crystalline Insulin from Obese 
and Lean Mice of the B L / 6 J Strain 195 
Bretzel, R.G., Ch. Breidenbach, J. Hofmann, 
K. Federlin 
Islet Transplantation in Experimental Diabetes 
of the Rat. V I . Rate of Regression in Diabetic 
Kidney Lesions after Isogeneic Islet Transplan-
tation: Quantitative Measurements 200 
Davidson, M.B., D. Casanello-Ertl 
Insulin Antagonism in Cultured Rat Myoblasts 
Secondary to Chronic Exposure to Insulin . . . 207 
Olefsky, J.M. 
Comparison of the Effects of Insulin and 
Insulin-like Agents on Different Aspects o f 
Adipocyte Metabolism 209 
Matsuyama, T., R. Tanaka, K. Shima, S. Tand 
Anomeric Specificity in the Response of Gut 
Glucagon-like Immunoreactive Materials to 
Glucose 214 
Baxter, R.C, A.S. Brown, J.R. Turtle 
Decrease in Serum Receptor-Reactive Somato-
medin in Diabetes 216 
Barber, S.G., AM. Hoare 
Cimetidine Effects on Prolactin Release and 
Production 220 
Poland, R.E., M.E. Weichsel, Jr., R.T. Rubin 
Postnatal Maturation Patterns of Serum Corti-
costerone and Growth Hormone in Rats: 
Effect of Chronic Thyroxine Administration . 222 
Vigouroux, E., J. Clos, J. Legtand 
Uptake and Metabolism of Exogenous and 
Endogenous Thyroxine in the Brain of 
Young Rats 228 
Sorimachi, K., HJ. Cahnmann 
Formation and Metabolism of 3', 5'-Diiodothy-
ronine and 3,5-Diiodothyronine by Cultured 
Monkey Hepatocarcinoma Cells 233 
Jones, CT. 
Normal Fluctuations in the Concentration of 
Corticosteroid and Adrenocorticotrophin in the 
Plasma of Foetal and Pregnant Sheep 237 
Horky, K, J. Sramkovd, J. Lachmanova, R. Tomä-
$ek. J. Dvofdkova 
Plasma Concentration of Antidiuretic Hormone 
in Patients with Chronic Renal Insufficiency 
on Maintenance Dialysis 241 
Blum, J.W., W. Biancy, F. Näf P. Kunz, J.A. 
Fischer, M. Da Prada 
Plasma Catecholamine and Parathyroid Hor-
mone Responses in Cattle during Treadmill 
Exercise at Simulated High Altitude 246 
Solter, M., M. Sekso 
Increased Posthyperglycemic Insulin Secretion 
Area in Obese Subjects with Asymptomatic 
Reactive Hypoglycemia 252 
Terpstra, J., L.W. Hessel, CM. van Gent, 
PH. van Reine 
Postprandial Insulin Response and Diurnal 
Triglyceride Pattern 253 
Frayn, K.N., PF. Maycock 
Apparent Effect of Octan-l-ol on Glycogen 
Metabolism in Muscle in Vi t ro 255 
Hayek, A. 
Unimpaired Gluconeogenesis in Congenital 
Hypothyroidism 256 
Pontiroli, A.E., G. Pellicciotta, M. Alberetto, 
A. De Pasqua, AM. Girardi, G. Pozza 
Cimetidine and L-Dopa in the Control of 
Prolactin Secretion in Man 257 
Wambach, G., J. R. Higgins 
Effect of Progesterone on Serum and Tissue 
Electrolyte Concentration in Doca-treated 
Rats 258 
Congress-Announcements 260 
Krause, U., G. Faisst, U. Cordes, J. Beyer 
Secretory B-Cell Act ivi ty in Insulin Dependent 
Maturity-Onset Diabetic 261 
Renauld, A., L.L. Andrade, R.C. Sverdlik, R. 
R. Rodriguez, D.M. Lindental 
Serum Insulin and Free Fatty Ac id Responses 
to Slow and Quick Graded Hyperglycaemias 
in Hypothyroid Dogs 265 
VI Table of Contents 
Herndon, Ch.M., D.S. Schade, R.Ph. Eaton 
The Differential Effect of Insulin in Vivo 
on the Peripheral Utilization of Glucose and 
Ketone Bodies in the Rat 270 
Uranga, J., R. Fuenzalida, A.L. Rapoport, 
E. del Castillo 
Effect of Glucagon and Glomerulopressin on 
the Renal Function of the Dog 275 
Taylor, W.M., R.B. Goldrick, T. Ishikawa 
Glycerokinase in Rat and Human Adipose 
Tissue: Response to Hormonal and Dietary 
Stimuli 280 
Paetzke-Brunner, /., G. Löffler, O.H. Wieland 
Activation of Pyruvate Dehydrogenase by 
Insulin in Isolated Brown Fat Cells 285 
Buse, M.G., R. Atwell, V. Mancusi 
In Vi t ro Effect of Branched Chain Amino 
Acids on the Ribosomal Cycle in Muscles of 
Fasted Rats 289 
Okuno, A.,T. Taguchi, K. Nakayama, 
M. Takimoto 
Kinetic Analysis of Plasma T S H Dynamics 
after T R H Stimulation 293 
Hagino, N., 
Effect of Nembutal on L H Release in 
Baboons 296 
Bastomsky, C.H., K. Banovac, F. Skreb, 
M. Sekso 
Similar Serum Concentrations of Thyroid Hor-
mones in Two Geographically Separate Popula-
tions on Disparate Iodine Intake 301 
Courtright, J.B., R.H. Fitts 
Effects of Thyrotoxicosis on Mitochondrial 
Enzymes of Rat Soleus 304 
Schöneshöf er, M., B. Schefzig, W. Oelkers 
Evidence of Adrenal 18-Hydroxylase Inhibi-
tion by Metyrapone in Man 306 
Wood, W.G., I. Marschner, P.C. Scriba 
Tests on Three Antisera and Subsequent De-
velopment of Radioimmunoassay for Diffe-
rent Regions of Human Parathyrin 309 
Ambrosi, B., M. Gaggini, F. Secchi, G. Faglia 
Lack of Effect of Antiserotoninergic and/or 
Dopaminergic Treatment in Patients wi th 
Pituitary-Dependent Cushing's Syndrome. . . . 318 
Spitz, I.M., B. Conen, R. Luboshitzky, E. Ro-
sen, O. Shemesh 
The Prolactin Response to Repeated Intra-
venous Stimuli 319 
Shima, K., A. Tanaka, N. Sawazaki, J. Hamabe, 
R. Tanaka, Y. Kumahara, N. Yanaihara 
Hypermotilinemia in Chronic Renal Failure . . 320 
Congress-Announcements 322 
Herberg, L. 
Spontaneously Hyperglycemic Laboratory A n i -
mals Models of Human Diabetes-Syndrome? 323 
Nattrass, M., L. Hinks, P. Smythe, P.G. Todd, 
K.G.M.M. Alberti 
Metabolie Effects of Combined Sulphonylurea 
and Metformin Therapy in Maturity-Onset Dia-
betics 332 
Harano, Y., S. Ohgaku, H. Hidaka, K. Takatsuki, 
Y. Shigeta 
Efficacy of Combined Insulin and Somato-
statin Infusion for the Treatment of Experi-
mental Diabetic Ketoacidosis 338 
Valverde, I., M. Ghiglione, R. Matesanz, 
S. Casado 
Chromatographie Pattern of Gut Glucagon-
Like Immunoreactivity (GLI ) in Plasma be-
fore and during Glucose Absorption . . . 343 
Simoes Nunes, C, T. Corring 
Pancreatic Exocrine Secretion in the Pig Fo l -
lowing Test Meals of Different Composition 
and Intra-Duodenal Loads of Glucose and 
Maltose 346 
Bieger, W., H. Weicker, A. Haymovits 
Amino Ac id Transport in the Exocrine Pan-
creas. IV. Do Glucagon or Insulin Mediate the 
In Vivo Effect of Caerulein on Amino Ac id 
Transport and Incorporation? 352 
Hagino, N., T. Koyama 
Luteotrophic Capacity of T R H in the Baboon 358 
Hendrich, Ch.E., S.P. Porterfield, VA. Galton 
Pituitary-Thyroid Function of Fetuses of Hy-
pothyroid and Growth Hormone Treated 
Hypothyroid Rats 362 
van Noorden, C.J.F., W.M. Wiersinga, J.L. 
Touber 
Propranolol Inhibits the In Vi t ro Conversion 
of Thyroxine into Triiodothyronine by Isolat-
ed Rats Liver Parenchymal Cells 366 
Wernze, H., H. Weiß 
Plasma Renin, Renin Substrate and Angioten-
sin II Changes Following Experimental Endo-
toxinaemia 371 
Streibl, W., H.Minne, F. Raue, R. Ziegler 
Radioimmunoassay for Human Parathyroid 
Hormone for Differentiation between Pa-
tients with Hypoparathyroidism, Hyperpara-
thyroidism and Normals 375 
Thomasset, M., P. Cuisinier-Gleizes, 
H. Mathieu 
Renal CaBP and Calcium Excretion in Phos-
phorus Depleted Rats 377 
Table of Contents VI I 
Washko, Ph.W., R.J. Cousins 
Effect o f Parathyroid Hormone on the Uptake 
of ü ra l ly Administered Cadmium 378 
Review 
Rosenthal, J. 
A n Apraisal of the Role of Aldosterone and 
the Sympathetic Nervous System in Essen-
tial Hypertension 379 
Verdy, M. 
Sodium Sparing Effect of Alanine in Fasting 
Obese Females 382 
Amqvist, HJ., H.H. Dahlkvist 
Effect o f Experimental Diabetes on the Incor-
poration of Amino Acids into Protein in Rat 
Aorta 384 
Schönberger, W., W. Grimm, R. Ziegler 
The Effect of (6-D-(o-tert-B)-Ser)-Gonadolibe-
rin-( 1-9) Nonapeptide-Ethylamide on Gonado-
tropin Release in Prepubertal Boys 389 
Tharandt, /.., H. Schulte, G.ßenker, K. Hacken-
berg, D. Reinwein 
Binding of Luteinizing Hormone Releasing Hor-
mone to Human Serum Proteins lnfluence 
of a Chronic Treatment with a More Potent 
Analogue of L H - R H 391 
Buckman, M.T., G.T. Peake, S. Srivastava 
Indomethacin Fails to Alter Basal or Pheno-
thiazine-lnduced Prolactin Concentrations in 
Man 395 
Karlsson, F.A., P.A. Dahlberg 
Human Thyrotropin Receptors are Expressed 
Independently of the State of Thyroid Hor-
mone Production in Thyroid Tissue 399 
Pinto, J.E.B. 
The Blocking Effect of Magnesium on the 
Secretion of Adrenal Catecholamines Induced 
by the Omission of Sodium from the Extra-
cellular Medium 404 
Weiß, M., M. Nagelschmidt, IL Struck 
Relaxin and Collagen Metabolism 408 
Owens, D.R., K.G. Wragg, K.T Shetty, PI. 
Biggs, CD. Davies 
Glibenclamide. Acute/Long-Term Response 
in M O . Diabetics 411 
Eversmann, T, R. Landgraf, W. Londong, 
K. von Werder 
Effect of Cimetidine on Prolactin-Secretion 
and Glucose Tolerance in Men 412 
Dash, R.J, B. Kumar, R. Sialy, G.K. Rastogi 414 
L H , F S H Responses to G n R H in Lepromatous 
Leprosy 413 
Congress Announcements 414 
Review 
Luft, R., S. Efendic 
Low Insulin Response Genetic Aspects and 
Implications 415 
Johansen, K., O. Munck 
The Relationship between Maximal Oxygen 
Uptake and Glucose Tolerance/Insulin Re-
sponse Ratio in Normal Men 424 
Richardson, D.K., M.P. Czech 
Diminished Activities of Fatty Acid Synthesis 
Enzymes in Insulin-Resistant Adipocytes from 
Spontaneously Obese Rats 427 
Gorray, K.C, W.B. Quay, R.B.L. Ewart 
Effects of Pinealectomy and Pineal Incuba-
tion Medium and Sonicates on Insulin Re-
lease by Isolated Pancreatic Islets In Vi t ro . . 432 
Larsson-Cohn, U., L. Wallentin, G. Zador 
Plasma Lipids and High Densitiy Lipoproteins 
during Oral Contraception with Different Com-
binations of Ethinyl Estradiol and Levonorges-
trel 437 
Ciavatti, M.. S. Renaud 
Modification by Oral Contraceptives in Rat of 
1 4 C Acetate Incorporation into Platelet Lipids 441 
Porterfield, S.P. 
The Effects of Growth Hormone, Thyroxine 
and Insulin on the Activities of Reduced Nico-
tinamide Adenine Dinucleotide Phosphate De-
hydrogenase, Glucose-d-Phosphatase and Gly-
cogen Phosphorylase in Fetal Rat l jver 444 
Cusack, D., C. Cannon, P. Skrabanek, 
D. Powell 
Substance P Plasma Levels in Pregnancy and 
in Various Clinical Disorders 448 
Shima, K., R. Tanaka, N. Sawazaki, Y. Kuma-
hara 
Relationship between Secretory Capacity 
of Pancreatic A Cell and of B Cell 45 1 
Werner, S. 
Human Pituitary Adenomas with Hypersecre-
tion of TSH and Prolactin. Evidence that Re-
ceptor Sites for Dopamin may be Absent on 
T S H Producing while Present on Prolactin 
Producing Cells 452 
Gilman, S., R. Thornton, D. Miller, R. Biersner 
Effects of Exercise Stress on Parotid Gland 
Secretion 454 
Aaby, R 
Concentration of Porcine Proinsulin-Like 
Material in Plasma of lnsulin-Treated Diabetics 
in Relation to Purity of Insulin Preparations 455 
Schusdziarra, V., V. Harris, R. Ungcr 
Response of Plasma Somatostatin-Like Immu-
noreactivity to the Administration of Al loxan 
in Dogs 457 
VIII Table of Contents 
Nooijen, W.J., HJ. Kempen 
Immunogenicity and Bioactivity of Glucagon, 
Modified at Methionine-27 459 
Ohneda, A., K. Watanabe, M. Wakimatsu, 
M. Fujino 
Production of a Specific Antiserum by Syn-
thetic C-Terminal Fragment of Glucagon . . . . 463 
Zawalich, W.S., E.S. Dye, F.M. Matschinsky 
Nicotinamide Modulation of Rat Pancreatic 
Islet Cell Responsiveness In Vitro 469 
Nutting, D.F., J.C. Zollinger, LJ. Coats 
In Vi t ro Effects of Fatty Acids on the Act ions 
of Serum on Rat and Pig Cartilage 472 
Sowers, J.R., B.F. Rice, S. Blanchard 
Effect of Dexamethasone on Luteinizing Hor-
mone and Follicle Stimulating Hormone Re-
sponses to L H R H and to Clomiphene in the 
Follicular Phase of Women with Normal 
Menstrual Cycles 478 
Hagino, N. 
Effect of Estrogen on Postovulatory L H 
Surge in Baboons 481 
Osterman, J., J.M. Hammond 
Effects of Epidermal Growth Factor, Fibro-
blast Growth Factor and Bovine Serum 
Albumin on Ornithine, Decarboxylase A c t i -
vity o f Porcine Granulosa Cells 485 
Hamaji, M., K. Nakao, K. Kiso 
Pancreatic Glucagon and Insulin Response 
during Surgery 488 
Rodway, R.G., H. Galbraith 
Effects of Anabolic Steroids on Hepatic En-
zymes of Amino Acid Catabolism 489 
Pils, P, P. Schmid, P. Schmidt, W. Schlick, 
J. Zazgornik, H. Kopsa, B. Balcke, E. Deutsch 
Continuous Body Weight Loss in Chronic 
Uraemia 491 
Bolli, G., M.G. Cartechini, P. Compagnucci, 
S. Malvicini, P. De Feo, F. Santeusanio, G. 
Angeletti, P. Brunetti 
Effect of Metabolie Control on Urinary Excre-
tion and Plasma Levels of Catecholamines in 
Diabetics 493 
Taketomi, S., H. Iwatsuka 
Effects o f a Synthetic Hexapeptide (ß-Ala-
Arg-Gly-Phe-Tyr-NH 2 ) on Insulin Binding 
and Glucose Metabolism of Rat Adipocytes . 498 
Mondola, P, L. Coscia Forrazzi, C. Falconi 
Cholesterol and Triglycerides of the Liver 
after Administration of a Chromatographie 
Fraction of Thymus: Variations in Tissue 
and Blood 503 
Laurberg, P, J. Weeke 
r T 3 Production in Normal Man, Assessed from 
Variations in Serum rT 3 during Short-Term 
r T 3 Infusion 506 
Nwosu, U.C., MM. Kaplan, R.D. Utiger, M. 
Delivoria-Papadopulos 
Plasma Triiodothyronines in Fetal Sheep: Effects 
of Illness and Thyroidectomy 509 
Uranga, J., E. Del Castillo 
Effect of Glomerulopressin on Ovarian Blood 
F low in Dogs 513 
Hodgkinson, A. 
Effects of Calcium Deprivation and Orchidecto-
my on Bone Composition in the Rat 516 
Corradino, R.A. 
Hydrocortisone and Vitamin D 3 Stimulation of 
3 2 Pj-Phosphate Accumulation by Organ-Cultured 
Chick Embryo Duodenum 519 
Peters, J.R., J. Rhodes, D.R. Owens 
Metabolie Effects of Altered Meal Frequency 
in Man 524 
Steele, N.C., R.J. Martin, CA. Baue 
Insulin Receptor Characteristics and Insulin 
Degradation by Zucker Lean and Obese Rats 525 
Mulloy, A.L., WJ. Visek 
Arginine-Induced Secretion of Insulin and 
Glucagon in Rats with Experimental Hyper-
ammonemia 527 
Spencer, G.S.G., M.B. Enser 
Plasma Somatomedin Act ivi ty in Obese-
Hyperglycemic Mice 528 
Malmquist, J., B. Israelsson, U. Ljungqvist 
Inhibition of Human Liver Membrane Adenyl-
ate Cyclase by Zinc Ions 530 
Jubelin, J., G. Lam Van, J. Boyer 
Effect of Estrogen on Heparin-Releasable Liver 
Lipases 531 
Congress Announcements 532 
Bohnet, H.G., A.S. McNeilly 
Prolactin: Assessment of its Role in the 
Human Female 533 
Greco, A.V., A.G. Rebuzzi, L. Altomonte, 
R. Manna, A. Bertolt, G. Ghirlanda 
Glucose. Insulin and Somatostatin Infusion 
for the Determination of Insulin Resistance 
in Liver Cirrhosis 547 
Saito, H., T. Ogawa, K. Ishimaru, /. Oshima, 
S. Saito 
Effect of Pentobarbital and Urethane on the 
Release of Hypothalamic Somatostatin and 
Pituitary Growth Hormone 550 
Table of Contents IX 
Bilkudel, B., B.Ch.J. Suttcr 
Direct Effect of Corticosterone upon Insulin 
Secrection Studied by Three Different Tech-
niques 555 
Kaciuba-Uscilko, H., Z. Brzezinska 
Effect of Thyroxine Treatment on Metabolie 
Responses to a Single Insulin Injection . . . 561 
Feldman, J.M., S.A. Weiss Jr. 
Adrenal-Cortical Function in Patients with 
Medullary Carcinoma of the Thyroid and 
Pheochromocytoma 567 
Siebenschein, R., W. Vetter, R.Leinert, W. Sie-
genthaler, H. Vetter 
Night-Day Variations of Renin-Activity in Pri-
mary Aldosteronism 570 
Lin, T., J. Marchwinski, H. Nankin 
In Vi t ro Studies of the Testis: The Effect o f 
L H on Cyclic Nucleotides 573 
Broulik, P.D., V. Pacovsky 
The Chloride Phosphate Ratio as the Screen-
ing Test for Primary Hyperparathyroidism . 577 
Damgaard, {]., J. Markussen 
Analysis of Insulins and Related Compounds 
by H P L C 580 
Flatt, RR., S.K. Swanston-Flatt 
Rapid Production of Potent Glucagon Ant i -
sera in the Guinea Pig 581 
Le Roith, D., M. Shapiro, K. Jabotinsky, 
IM. Spitz 
Prolactin Nonresponsiveness to Arginine in 
Diabetes Mellitus 583 
Gecse, A., A. Ottlecz, M. Farago, T. Forst er, 
G. Telegdy 
The Effect of A C T H and its Fragments on 
the In Vitro Metabolism of Prostaglandins . 585 
Spencer, G.S.G. 
Circadian Variation of Somatomedin and 
Cortisol in Pigs 586 
Girndt, J., H.V. Henning, G. Delling 
Correlation of Calcium and Acid-Base 
Metabolism 587 
Congress Announcements 588 
Grube, D., W.G. Forssmann 
Morphology and Function of the Entero-
Endocrine Cells 589 
Haeckel, R., M. Oellerich 
Hydrazonopropionic Acids. a New Gass of 
Hypoglycemic Substances. 1. Hypoglycemic 
Effect of 2-(Phenylethyl-hydrazono)- and 
2-(2-Cyclohexyl-ethylhydrazono)-Propionic 
Acid 606 
Pschera, H., I. Björkhem, K. Carlström, O. 
Lantto, N.O. I.unell, B. Persson, C. Somell, 
M. Stangenberg, J. Wager 
Total Cortisol and L/S-Ratio in Amniotic 
F lu id in Late Pregnancies Complicated by 
Diabetes Mellitus 612 
Blossey, PI.Chr. 
Studies on the Molecular Architecture and 
the Composit ion of the G H Receptor from 
Rabbit Liver 616 
Hopf, U., T.H. Hütteroth, P. Kotulla 
Demonstration of Circulating Immune Comple-
xes in Graves' Disease by the Raji Cell Tech-
nique and their Relation to Different Thyroid 
Autoantibodies 622 
Llobera, M., A. Muniesa, E. Herrera 
Effects o f Hypo- and Hyperthyroidism on In 
Vivo Lipogenesis in Fed and Fasted Rats. . . . 628 
Schweikert, H. U. 
Conversion of Androstenedione to Estrone 
in Human Fibroblasts Cultured from Prostate, 
Genital and Nongenital Skin 635 
Petralito, A., M. Lunetta, A. Liuzzo, R.A. 
Mangiafico, C.E. Fiore 
Effects o f Salmon Calcitonin on Insulin-
lnduced Growth Hormone Release in Man . 641 
Rizza, R., C. Verdonk, J. Miles, F.J. Service, 
M. Haymond, J. Gerich 
Somatostatin does not Cause Sustained Fast-
ing Hyperglycemia in Man 643 
Olsen. R.F, W.II. Patton, R.J. Martin, P.J. 
Wangsness 
Serum Somatomedin and Fibroblast Prolifera-
tive Act iv i ty with Growth Hormone Injection 
in Hypophysectomized and Sham-Operated 
Rats 645 
York, D.A., V. Godbole 
Effect o f Adrenalectomy on Obese 'Fat ty ' 
Rats 646 
Bray, G.A., W.T. Dahms, R.L. Atkinson, J. 
Rodin, I. Taylor, C. Frame, A. Schwartz 
Metabolie and Behavioral Differences be-
tween Dieting and Intestinal Bypass 648 
Schwedes, U., PH. Althoff, I. Klempa, U. 
Leuschner, L. Mothes, S. Raptis, J. Wdowinski, 
K.H. Usadel 
Effect o f Somatostatin on Bile-Induced Acute 
Hemorrhagic Pancreatitis in the Dog 655 
Nosadini, R., F. Ursini, C. Garotti, A. Tiengo, 
C. Gregolin 
Perfused Liver Carnitine Palmitoyl-Transferase 
Act iv i ty and Ketogenesis in Streptozotocin 
Treated and Genetic Hyperinsulinemic Rats. 
Effect of Glucagon 661 
X Table of Contents 
Laczi, F., J. Julesz, T. Janaky, FA. Laszlö 
Growth Hormone Reserve Capacity in Turner's 
Syndrome 664 
Geierhaas, B., M. Herrmann 
About the Relationship between Adrenal Cor-
text and Thyroid Gland of Rats (Shift-Effect) 666 
Stephan, F., Ph. Reville, F. de Laharpe, M.J. 
Compagnie 
Influence of Nutritional Factors on the Reno-
trophic Act ion of A C T H in the Uninephrectom-
ized Rat 669 
Brzezinska, Z., H. Kaciuba-Uscilko 
Low Muscle and Liver Glycogen Contents in 
Dogs Treated with Thyroid Hormones 675 
Morley, J.E., L.A. Distiller, I. Lissoos, R. Lip-
schitz, G. Kay, D.L. Searle, M. Katz 
Testicular Function in Patients with Spinal 
Cord Damage 679 
Hannappel, E., U. Drews 
Mosaic Character of Spermatogenesis in Car-
riers of the Sex Reversed Factor in the Mouse 682 
Csaba, G., O. Dobozy, G. Kaizer 
Study of FSH-TSH Functional Overlap 
by Cockerel Testicle Test 689 
Caviezal, E., M. Poli, M. Murari, AM. Girardi, 
G. Pozza 
Influence of Therapeutic Doses of Vincristine 
on the Arginine-induced Insulin and Growth 
Hormone Secretions in Man 692 
Susini, C., M. Lavau, J. Herzog 
Insulin Effect In V i v o on the Act ivi ty o f Ace-
tyl-Coenzyme A Carboxylase in Adipose Tis-
sue of Rats Fed a Low or a High-fat Diet . . 694 
de Mendoza, S.G., H. Nucete, E. Salazar, A. 
Zerpa, M.L. Kashyap 
Plasma Lipids and Lipoprotein Lipase Activa-
tor Property during the Menstrual Cycle . . . . 696 
Passia, D., B. Hilscher, H.G. Goslar, W. Hil-
scher, N. Hofmann 
Thiamine Pyrophosphatase TPPase as a 
"Marker Enzyme" of the Germ Cells in the 
Rat 697 
Hope-Gill, H.F., V. Nanda 
Stimulation of Calcium ATPase by Insulin. 
Glucagon, Cyclic A M P and Cycl ic G M P in 
Tri ton X-100 Extracts of Purified Rat Liver 




Aaby, P. 455 
Alberetto, M . 257 
Alberti , K . G . M . M . 332 
Alric, R. 95 
Altomonte, L . 547 
Althoff, R H . 655 
Ambrosi. B. 318 
Andrade, L . L . 265 
Angeletti, G. 493 
Arnqvist. H.J . 384 
Atkinson, R . L . 648 
Atwell . R. 289 
B 
Baba, S. 23 
Babicky, A . 83 
Baile, C A . 525 
Balcke, P. 491 
Bamji. M.S. 64 
Bandisode. M.S. 187 
Banqyac, K. 301 
Baianao, J , L . 161 
Barber, S.G. 220 
Bark. H. 177 
Barlct. J .P . 57 
Bass. A . 6 
Bastomsky, C . H . 301 
Baxter. R.C. 216 
Benker, G . 391 
Benveniste. R. 165 
Bertoli. A . 547 
Beyer. J . 195. 261 
Bianca. W. 246 
Bieger, W. 35 2 
Biersner, R. 454 
Biella de Souza Valle. L. 
161 
Biggs, P.I. 77. 41 1 
Billaudol, B. 555 
Birnbaum. R.S. 1 36 
Björkhem, I. 612 
Blackard. W.G. 149 
Blanchard, S. 478 
Blayac, J.R 95 
Blossey. H.Chr. 616 
Blum. J.W. 246 
Boer. 1». 47 
Bohnet, H . G . 5 33 
Bol l i . G. 493 
Boshell, B.R. 187 
Botha. A . 78 
Boyer. J . 5 31 
Braendle, W. 60 
Brandenberger, G . 180 
Bray. G . A . 647 
Breidenbach, Ch. 200 
Bretzel, R . C 200 
Briaud. B. 130 
Button. B.J. 52 
Broulik. (>. D. 577 
Brown. A.S . 216 
Brunetti, R 493 
Bryce, G . K 90 
Brzezinska. Zofia 561. 675 
Buchanan. K . D . 19 
Buckman. M.T. 395 
Buse, Maria G . 289 
C 
Cahnmann, H.J . 233 
Calvo, J .C. 161 
Cannon, D. 448 
Carls t röm, K . 612 
Carrillo. B.J . 5 7 
Cartechini, Maria G. 49 3 
Casado, S. 343 
Casanello-Ertl, Delia 207 
Caviezal, E. 692 
Charreau, E . H . 1 61 
Ciavatti, M . 441 
Clos, J . 228 
Coats, Linda J . 472 
Cohen. R. 174 
Compagnie, M. J . 669 
Compagnucci, R 493 
Conlon, J .M. 19 
Cordes, U. 261 
Corradino, R . A . 519 
Corring, T. 346 
Coscia Porrazzi, L . 503 
Courtright, J .B. 304 
Cousins, R . J . 378 
Cuisinier-Gleizes, Paulette 
377 
Curbelo, H . M . 155 
Cusack, D. 448 
Csaba, G . 689 
Czech, M.R 427 
D 
Dahlberg, P.A. 399 
Dahlkvist, H . H . 384 
Dahms. W.T. 647 
Dambacher. M . A . 168 
Damgaard, U. 580 
Da Prada, M . 246 
Darwish, Suzan A . E . 44 
Dash, R . J . 413 
Davic io , Marie Jeanne 57 
Davidson, M.B. 207 
Davies, C D . 77, 41 1 
De Fco . R 493 
Del Castillo, F. 275, 
513 
Delivoria-Papadoupoulos, 
M . 509 
Delling. G . 587 
Deutsch, E. 491 
Dietze. G . 1 
Distiller, L . A . 68. 679 
Dobozy, O. 689 
Doerr, R 181 
Donald. R . A . 142 
Dorhout Mees, E.J . 47 
Drews, U . 682 
Duhm. A . 107 
Dubuc, R U . 37 
Dvofakova. J. 241 
Dye, Evelyn S. 469 
E 
Eaton. R. 2 70 
Efendic. S. 415 
Enser. M . B . 528 
Epstein. S. 68 
Ei te l . N . 30 
Eversmann. 1. 412 
Ewart, R . B . L . 432 
Faber. J. 34 
Faglia, G . 318 
Faber, J. 34 
Faglia, G . 318 
Falconi, C. 503 
Faisst. G . 261 
Faragd, M . 585 
Federlin. K . 200 
Feldman, J .M. 567 
Fiore, C E . 641 
Fischer. J .A . 246 
Fitts. R . H . 304 
Flatt. P.R. 581 
Foä, P.P. 100 
Follenius. M . 180 
Forssmann, W.G. 589 
Forster. T. 585 
Frame. C. 648 
Fräser, W . M . 149 
Frayn, K. .N. 255 
Friis. I. 34 
Fuenzalida, Rebeca 275 
Fujino, M . 463 
Furman, B . L . 44 
G 
Gaggini, M . 318 
Galbraith, H . 489 
Galton, Valerie A . 36 2 
Garmendia, F. 81 
Garotti , C. 661 
Gecse, A . 585 
Geierhaas, B. 666 
Cent. C M . van 25 3 
Gerich, J . 643 
Gero, F. 72 
Ghiglione, Margarita 343 
Ghirlanda, G . 547 
Giannetto. B.O. 80 
Gilman, Sara 454 
Girard, Anik 118 
Girardi, A . M . 257, 691 
Girndt, J . 587 
Gl ick , S .M. 177 
Goberna. R. 183 
Godbole, V. 646 
Gold . C. 68 
Goldberg. R .B . 78 
Goldbrick, R .B . 280 
Gonen, B. 319 
Goodman. H . M . 1 36 
Gorray. K . C . 432 
Goslar, H . G . 697 
Greco, A . V . 547 
Gregolin, C. 660 
Griglio, S. 118 
Gr imm, W. 389 
Griswold, M.D. 80 
Grubb. S.R. 149 
Grube. D. 589 
Guncaga, J. 168 
Guzdck. A . 107 
H 
Haas. H . G . 168 
Hackenberg, K. 391 
Haeckel. R. 606 
Hagino. N . 296, 358, 
481 
Hainer. V. 178 
Hamabe, J . 320 
Hamaji, M . 488 
Hammond, J . M . 485 
Hannapel. Elisabeth 682 
Hansen, B. 85 
Harano, Y. 338 
Harris, Virgina 457 
Hartmann, F. 158 
Hasegawa, M . 23 
Havelka, S. 83 
Hayek, A . 172,256 
Haymond, M . 643 
Haymovits. A . 352 
Hawrylko. J . 173 
Herberg, Lieselotte 
195. 323 
Hendrich. Ch . E. 362 
Henning, H .V. 587 
Heindon. Ch. M . 270 
Hcrrera, E. 628 
Herrmann, M . 666 
Herzog, J. 694 
Hessel, E.W. 253 
Hidaka, H. 338 
Higgins, J .R. 258 
Husche;-, B. 697 
Hilscher. W. 697 
Hinks, L . 332 
lloare, A . M . 220 
Hodgkinson. A . 516 
Hofmann, J . 200 
Hofmann. N . 697 
Hol lo . I. 72 
Honey, R . N . 1 1 I 
Hopf, ü . 622 
Hoppe-Gill , H .E . 698 
Horky, K. 241 
Houssay, A . B . 155 
Hatterath, I.II. 622 
I 
Irving, M . H . 52 
Ishikawa. I. 280 
Ishimaru, K. 550 
Israelsson, B. 5 30 
Ito, S. 184 
Iwatsuka. H . 498 
.1 
Jabotinsky, K. 583 
Jacoby, J . H . 90 
Janaky, T. 664 
Jensen. Frida 85 
Jentzen. F. 158 
Joffe, B.E 78 
Johansen, K . 424 
Jones, C T . 2 37 
Joost, H . G . 104 
Jubelin, J. 531 




X I I Author's index 
Kaizer, G . 689 
Kalk , J . 68 
Kalopissis, A . D . 118 
Kansal, P.C. 187 
Kaplan, M M . 509 
Karliner. E . C . 155 
Karlsson, F . A . 399 
Kashyap, M.L.. 696 
Kather, H . 176 
Katz , M . 68, 679 
Kay , G . 679 
Kaye, G . 68 
Kayamori , R. 184 
Kempen, H . J . 457 
Kenner, A . 165 
Kesserü, E . 81 
Kirkegaard, C. 34 
Kiso, K . 488 
Klempa. [. 655 
Kobayashi, T. 23 
K o c h , B. 130 
Kollendorf, K . 85 
Kopsa, H . 491 
Koränyi , L . 72 
Kotul la , P. 622 
Koyama, T. 358 
Krause, U . 195, 261 
Krejcik. L . 178 
Kronheim. S. 79 
Kubek, M . J . 26 
Kuehn, Cynthia 1 72 
Kukulansky, Tova 14 
Kumahara, Y. .320, 451 
Kumar, B. 413 
Kunz , P. 246 
L 
Lachmanovä . J . 241 
Laczi , E. 664 
Lämmle, B. 168 
l.aharpe, F. de 669 
Lakshmaiah, N. 64 
Lam Van ,G . 531 
Landgraf, R. 412 
Lantto, O. 612 
Larsson-Cohn, Li. 437 
La'szld, F . A . 664 
Lavau, M . 694 
Lauffenburgcr, T. 1 68 
Laurberg, P. 506 
Leest hma, J .E . 26 
Lefaivre. J . 5 7 
Legrand, J . 228 
Leinert, R. 570 
Le Ro i th , D. 583 
Le Ro i th , D. 177 
Leuschner. U . 655 
Ein, T. 573 
Linde. Susanne 85 
Lindental , D . M . 265 
Lipschitz. R. 679 
Lissoos, I. 679 
Liuzzo, A . 641 
Liversey. J H . 142 
Ljungquist, U. 530 
Llobera, M . 628 
Löfner, G . 285 
L o m b a r d e Y . B . 9 
Londong, W. 412 
Loubatieres-Mariani, 
M . M . 95 
Euboshitzky, R. 319 
Luft, R. 415 
Lumhol tz , l . B . 34 
Lunel l , N . O . 612 
Lunetta, M . 641 
Lutz-Bucher, B. 1 30 
Luz io , J.P. 174 
M 
Macnab, M . 78 
Makimura, H . 23 
Malmquist, J . 530 
Malvicini , S. 493 
Mancusi, V. 289 
Mangiafico, R . A . 641 
Manna, R. 547 
Manougian, A . 30 
Marchwinski, J . 573 
Markussen, J . 580 
Marschner, I. 309 
Mart in. R . J . 525. 643 
Matcsanz, R. 343 
Mathieu, H . 377 
Matschinsky, F . M . 469 
Matsuyama, T. 214 
Maurer, W. 60 
May, P. 30 
Maycock, Paula, F. 255 
Mc Nei l ly , A . S . 533 
Menahan, E . A . 9 
Mendoza, S .G. de 695 
Mialhe, C . 130 
Mialhe, P. 123 
Micossi, P. 100 
Miles, J . 643 
Miller, D. 454 
Minne. H . 375 
Mittler, J . 30 
Mobley, P.W. 37 
Mdlholm Hansen, J . 34 
Mondola, P. 503 
Mordasini, R. 176 
Morley J .E . 68, 679 
Mothes, L . 655 
Mulloy, A . E . 527 
Munck, O. 424 
Muniesa, A . 628 
Murakami. K . 2 3 
Murari. M . 691 
Murphy, R .F . 19 
Musilova, J . 83 
N 
Naf, F. 246 
Nagelschmidt, M . 408 
Nakao, K . 488 
Nakayama, K . 293 
Nanda. V. 698 
Nankin, H . 573 
Nattrass, M . 332 
Nooijen, W.J . 459 
Noordcn, C . J . F . van 366 
Nosadini, R. 661 
Nucete, H . 696 
Nutting, D . E . 472 
Nwosu, U .C . 509 
O 
ü ' C o n n o r . I . A . 19 
üe lke r s . W. 306 
Oellerich. M . 606 
ügawa , T. 550 
ü h g a k u . S. 338 
Ohneda, A . 463 
ü k u n o , Akimasa 293 
Olah, J . 168 
ülefsky, J . M . 209 
Olsen, R . F . 645 
ü s h i m a , I. 550 
Oster, P. 176 
Osterman, J . 485 
Ottlecz, A . 585 
Owens, D.R. 77, 41 1, 524 
P 
Pacovsky, V. 5 77 
Paetzke-Brunner. 1. 285 
Palmieri, G . M . A . 173 
Pasqua, A . De 257 
Passia, D. 697 
Patton, W.H. 643 
Peake, G.T. .395 
Pellicciotta, G. 25 7 
Persson, B. 612 
Peters, J .R. 524 
Petralito. A . 641 
Pils, P. 491 
Pimstone, B. 79 
Pintado. E. 183 
Pinto, J .E .B . 404 
Pokroy. M . 68 
Poland, R . E . 222 
Poli , M . 691 
Pontiroli, A . E . 100, 257 
Porterfield, Susan, P. 362, 
444 
Powell, D. 448 
Pozza, G . 257, 691 
Prieto, J .C. 183 
Price, S. 111 
Pschera. 11. 612 
Puett, D. 165 
0 
Ouay, W.B. 432 
R 
Rahinowitz, D. 165 
Radö, J.P. 47 
Rapoport, Ana L'a 275 
Raptis, S. 655 
Rastogi, G . K . 413 
Rath, R. 6 
Raue, F. 375 
Rebuzzi, A . G . 547 
Reine. P .H. van 253 
Reinhardt. B. 180 
Reinwein. D. 391 
Renauld. Aurora 265 
Renauld, Aurora 190 
Renaud. S. 441 
Reville, Ph. 669 
Rhodes, J . 524 
Rice, B.F. 478 
Richardson, D .K . 427 
Rizza, R. 643 
Robbins, J . 39 
Rodin . J . 648 
Rodriguez. R R . 190, 265 
Rodway, R . G . 489 
Rohozkova. D. 83 
Rosen, E. 319 
Rosenthal, J . 379 
Rubin, R .T . 222 
Ruiz, G . 183 
Rutherford, R. 147 
S 
Sagel, J . 68 
Saito, H . 550 
Saito, S. 550 
Sakoda, M . 23 
Salazar, E . 696 
Santeusanio, F. 493 
Sara, V i c k i , R. 147 
Sarnecka-Keller, M . 107 
Sawazaki, N . 320, 451 
Schade, D.S. 270 
Schefzig, B. 306 
Schleiffer, R. 130 
Schlick, W. 491 
Schliert", G . 176 
Schmid, P. 491 
Schmidt, P. 491 
Schöneberger, W. 389 
Schöneshöfer, M . 306 
Schulte, H . 391 
Schusdziarra, V. 45 7 
Schwanz, A . 648 
Schwedes, U . 655 
Schweikert, H . U . 635 
Scott, R.S. 142 
Scriba. P.C. 309 
Searle, D L . 679 
Secchi, F. 318 
Settel, H .C. 78 
Seki, M . 23 
Sekso, M . 252, 301 
Service, F.J . 643 
Shapiro. B. 79. 583 
Shemcsh. O. 319 
Shetty, K . J . 77 
Shetty, K T . 411 
Shibata. A . 184 
Shigeta, Y. 338 
Shima. K . 214. 320. 
451 
Sialy, R. 413 
Siebenschein, R. 5 70 
Siegenthaler, VV. 570 
Siersbaek-Nielsen, K . 34 
Simatupang. T. 47 
Simeoni. M . 180 
Simoes. Nunes. C. 346 
Simon, B. 176 
Sitbon. G . 123 
Skovsted, L. 34 
Skrabanek, P. 448 
Skreb, F. 301 
Smythc. O .A . 147 
Smythe, P. 332 
Sobrino. F. 183 
Solter, M . 252 
Somell, C. 612 
Sorimachi, K . 39, 23 3 
Sowers. J .R. 478 
Spencer, G.S .G. 528 
528. 586 
Spitz, I M . 319. 583 
Sramkova. J . 241 
Srivastava. S. 395 
Stangenberg. M . 612 
Author 's Index XIII 
Stärk;,. L. 178 
Steezek. Katalin 72 
Steele, N .C . 525 
Stephan, F. 669 
Streibl, W. 375 
Struck, H. 408 
Susini, C. 694 
Sutter, B . C h J . 555 
Sverdlik, R . C . 190, 265 
Swanston-Flatt, S.K. 581 
Szalay, F. 72 
T 
Taguchi, T. 293 
Takatsuki, K . 338 
Taketomi, S. 498 
Takimoto, M . 293 
Tanaka. A . 320 
Tanaka. R. 214, 320, 451 
Taniguchi, H . 23 
Tarui. S. 214 
Taylor. 1. 648 
Taylor, W.M. 280 
Teisinger, J. 6 
Telegdy, G . 585 
Terpstra, J . 253 
Tesirek, B. 83 
Tesone, M . 161 
Tharandt, L . 391 
Theilade, P. 34 
Thomasset, Monique 377 
Thornton, R. 454 
Tiengo, A . 661 
Tober, C. 195 
Todd, P .G. 332 
Tomäsek, R. 241 
Touber, J .L . 366 
Tsutou, A . 2 3 
Tucker, H.St. 149 
Turtle, J .R. 216 
U 
ünger , R. 457 
Uranga, Julia 275. 513 
Urbanek, J . 178 
Urdanivia. E. 81 
Ursini, F. 661 
Usadel, K . H . 655 
Utiger, R . D . 509 
Utsumi, M . 23 
V 
Valette, G . 95 
Vaverde, Isabel 343 
Verdonk. C. 643 
Verdy. M . 382 
Vetter. H . 570 
Vetter. W. 570 
Vigouroux, E . 228 
Visek, W.J . 527 
Vitek, V. 6 
Vondra, K . 6 
W 
Wager. J . 612 
Wakimatsu, M . 463 
Wallentin. L . 437 
Wambach, G . 258 
Wangsness. P.J. 645 
Washko, Ph. W. 378 
Watanabe. K . 463 
Watanabe, Y. 2 3 
Weeke. J . 506 
Weichsel. M . E . Jr. 222 
Weicker. H . 352 
Weiss, H . 371 
Weiss, Marija 408 
Wells, S .A. , Jr. 567 
Werder, K . von 412 
Werner, Sigbritt 452 
Wernzc, H. 37 1 
Wdowinski, J . 655 
Wicklmayr, W. 1 
Wieland, O . H . 285 
Wiersinga, W . M . 366 
Wigand, J.P. 149 
Wilber, J .F . 26 
Wood, W.G. 52, 309 
Wragg, K . G . 77, 411 
Yagil, G . 14 
Yanaihara. N . 320 
Yamada, Y. 184 
York, D . A . 646 
Z 
Zador. G . 437 
Zawalich, W.S. 469 
Zazgornik, J . 491 
Zerpa, A . 696 
Ziegler, R. 375, 389 
Zollinger, Jane C. 472 
SUBJECT INDEX 
A 
Absorption of Insulin 85 
A Cell (Pancreatic) Reactivity, 
Juvenile Diabetics 45 1 
Acety l Coenzymc A Carboxy-
lase 427, 693 
Acid-Base Metabolism. Calcium 587 
A C I H 158. 318 
Anterior and Posterior Pituitary 
1 30 
Effect on Prostaglandins in vitro 
585 
Heat Exposure 180 
Renotrophic Act ion 669 
Acute Pancreatitis 655 
Adenylate Cyclase, Human Fat 
Cells 176 
l ive r . Zinc Ions 5 30 
Adipocytcs, Insulin Resistance 427 
Metabolism 209 
Adipocyte Plasma Membrane 174 
Adipocytes, Rat, Insulin Binding 
and Glucose Metabolism 498 
Adipose Tissue 1 36 
Enzymes of Energy Metabolism 6 
- Fat Diet 694 
- Glyccrokinase 280 
Obese Mice 195 
- (subcutaneousl 176 
Adrcnal Catecholamines, Na-Depriva-
tion, Magnesium 404 
Adrc-nal Cortex 666 
Adrenal-Cortical Function, Medullary 
( arcinoma of the Thyroid and 
Pheodiromocytoma 567 
Adrenalectomy, Obese "Fa t ty " Rats 
646 
Adrenalectomized Rats 172 
Adrenalectomy 130,261 
Adrenal Function, Prolactin 540 
Adrenal, 18-Hydroxylation 306 
Adrenaline, Fat Cells 176 
Adrenaline Thyroxine Treatment 
561 
Adrenergic Blockade, Plasma Ca-
techolamine Levels 52 
Adrenergic Receptor Blockade 90 
Adrenocorticotrophin, T'luctuations 
in Sheep 237 
African white tailed rat 327 
Alanine, Obesity 382 
Sulfonylureas and Metformin 332 
Aldosterone 379, 570 






TSH Levels 155 
Amino Acids, Branched Chain 289 
Catabolism, Anabolic Steroids 
489 
Exocrine Pancrcas 35 2 
Aminophylline 190 
Amniotic F lu id , Diabetic Pregnancv 
612 
Amylase. Pancreatitis 655 
Anabolic Steroids, Hepatic Enzymes 
489 
Androgen Binding Protein 80 
Androstenedione, Conversion to 
Estrone 635 
Angiotensin II 371 
Anomer, Glucose 214 
Antidiuretic Hormone 241 
Antidiuretic Hormone, Secretion, 
Somatostatin 177 
Ant iHCG-Serum 165 
Antihistaminic Agents, Gluca-
gon and Insulin Release 100 
Antiserotonincrgic Treatment, 
Cushing's Syndrome 318 
Aorta, Rat, Protein Synthesis, 
Experimental Diabetes 384 
Arginine-lnduced Insulin and 
Growth Hormone Secretion 
692 
Arginine, Insulin and Glucagon 
Secretion 527 
Plasma 241 
Prolactin Release 583 




Baboons 358, 481 
BB rat 324 
Beta-Cell Membrane 104 
B Cel l (Pancreatic) Reactivity, 
Juvenile Diabetics 451 
Residual Secretion 261 
B H E rat 328 
Blood Glucose. Sulfonylureas and 
Metformin 332 
Blood Sugar. Hyperthyroidism 190 
Hypothyroid Dogs 266 
Body Weight Loss, Chronic Uraemia 
491 
Bone Disease, Calcium 516 
Brain, Developing Thyroxine 228 
Growth-Promoting Activi ty 147 
Brattleboro Rats 130 
X I V Subject Index 
Bromocriptine. Pituitary Adenoma 
452 
Brown Adiposc l'issuc 285 
Bypass, Intestinal 648 
C 
1 1 5 m C a d m i u m 378 
C'admium Uptake 378 
Caerulein 352 
Calcitonin 184, 567 
Calcium Levels 73 
- Growth Hormone Release in 
Man 641 
Calcium 7 3 
Absorption 168 
- Acid-Base Metabolism 587 
ATPase 698 
- Balance 168 
-Binding Protein, Renal 377 
519 
- Diet 378 
Dietary 516 
- Excretion 377 




Carbohydraterich Diet 253 
Carnitine 78 
Palmitoyl Transferase (CPT) 661 
Cartilage, Fatty Acids 472 
Metabolism 83 
Castration, Bone Composition 516 
Catecholamines, Adrenal, Magne-
sium, Natrium deprivation 404 
- Diabetes 493 
Lxcrcise 246 
- Plasma 52 
C C K , Pancreatitis 655 
Childhood, Prolactin 5 34 
Chinese Hamster 326 
Cholesterol 118 
Liver 503 
Chloride Phosphate Ratio, 
Primary llyperparathyroidism 577 
Chloride Reabsorption 275 
Chlorphentermine 158 
Chlorpropamide. Diabetes 77 
Chromatography, Insulin 580 
Chronic Uraemia, Continuous Body 
Weight Loss 491 
Cimetidine, Effects on Prolactin 220 
Glucose Tolerance 412 
Prolactin 257 
Secretion 412 
Clomiphene, Gonadotropins 478 
Collagen Metabolism, Relaxin 408 
Conjugase 64 
Contraceptives, Platelet Lipids 441 
Contraception, Postcoital, Carbohy-
drate Metabolism 81 
Corticosteroid in Plasma, Shecp 237 
Corticosterone 222 
• Insulin Secretion 555 
Urinary. Blood and Adrenal 158 
Cortisol 318 
- Circadian Variations 586 
Cyproheptadine Pretreatment 1 78 
Diabetic Pregnancy 612 
Cortisol, Free, in Urine 567 
C-Peptide, Diabetics 261 
('-Regional Fragments, Parathyrin 
309 
Culture, Hepatocarcinoma Cells 
233 
Cultured Monkcy Hepatocarcinoma 
Cells 39 
Cushing's Syndrome 318,567 
Cycl ic A M P , Calcium ATPase 698 
cyclic A M P , Plasma 183 
- Relaxin 408 
Testis 573 
Cycl ic G M P , Calcium ATPase 698 
- Testis 57 3 
Cycl ic Necleotides, Testis 573 
2-(2-Cyclohexyl-Ethylhydrazono)-
Propionic Acid 606 
Cyproheptadine, Cushing's Syndrome 
318 
Pretreatment, Serum Cortisol 
Levels 178 
Cytogenesis, Maturation, and Cell 
Cycle, Entero-Endocrine Cells 
600 
D 
2-Deoxy Glucose, Adipocytes 209 
Desoxycorticosterone-acetat 258 
Dexamethasone, Gonadotropins and 
L H R H 478 
Dexchlorpheniramine 100 




Ketone Body Metabolism 1 
Eeydig Cell Enzymes 161 
Mellitus, Acute/Long- Term Re-






Diabetic Animals 606 
Insulin Dependent Maturity Onset 
261 
Juvenile Pancreatic A and B Cel l 
Reactivity 451 
Kctoacidosis 142 
Purity of Insulin Preparations 455 
Stupor 78 
Diamide 209 
Diet, Exocrine Pancreas 346 
Diiodothyronines 233 
Diurnal Fluctuation, A C T H and Cor-
ticosteroids in Sheep 237 
Diurnal Rhythm, Plasma Lipoproteins 
and Liver Lipids 1 I 8 
D|ungarian hamster 327 
Dog 177. 214 
Hyperthyroidism 190.266 
Pancreatitis 655 
Dopaminergic Treatment. Cushing's 
Syndrome 318 
Dopamine, 1 1 -Hydroxy-corticosteroids 
44 
Pituitary Adenoma 45 2 
Duodenum, Organ-Cultured 519 
E 
Electron Microscopy, Entero-Endocrine 
Cells 591 
Endocrine Cells, Gut 589 
Endotoxinaemia 371 
Energy Metabolism Enzymes 6 
Entero-Endocrine Cells 589 
Enzymes, Energy Metabolism 6 
Epidermal Growth F'actor 485 
Epinephrine, Diabetes 493 
Estradiol, Ethinyl- 437 
Estrogen, Lipase Activi ty 531 
- Nembutal 296 
- Postovulatory L H Surge 481 
Estrone Formation 635 
Evisceration, Rat 270 
Exercisc Stress, Parotid Secretion 454 
Treadmitl 246 
Exocrine Pancreas 346 
Amino Acid Transport 352 
Experimental Diabetes, Protein Synthesis, 
Rat Aorta 384 
F 
Fasting 270 
- Muscle 289 
Obesity 382 
- Rats, Plasma c-AMP Concentration 183 
Fat 270 
- Cell Adcnylate Cyclase 176 
- Cells, Isolated Pyruvate Dehydrogenase 
285 
Diet 14, 118, 694 
Fatty Acids, Cartilage 472 
Plasma Non-Esterified, Sulfonylureas 
and Metformin 332 
- Synthesis, Insulin-Resistance 4 27 
Synthetase, Effect of Insulin on 14 
Fetal Distress, Sheep 509 
Fetal Growth 147 
Fetal Rat Liver Enzymes, Growth Hormone 
Thyroxine and Insulin 444 
Fetus, Calcium Levels 57 
T I A Somatostatin 338 
Fibroblast Growth Factor 485 
Proliferative Activity 645 
Culture 635 
Fluoxetine 90 
Folate Metabolism 64 
Methyl 64 
Non-Methylated 64 
Forearm, Ketone Body Metabolism 1 
Foreskin 635 
Free Fatty Acids Hyperthyroidism 190 
Serum, Hypothyroid Dogs 266 
- Thyroxine Treatment 561 
Fructose Oxidation, Rat Adipocytes 498 
FSH 68 
FSH-TSH-Receptor Maturation 689 
G 
Galactorrhea 68 
Gastrin, Pancreatitis 654 
Genetic Aspects, l o w Insulin Response 
415 
Genetic Obesity (Zücker Rat) 661 
Geographica! Differences, lodine Intake 
301 
Germ Cells. Rat 697 
Glibenclamide. Acute/Long-Term Response 
41 I 
Subject Index X V 
Gl . l / IRI 123 
Glomerular Filtration Rate 275 
Glomerulopressin 275 .513 
Glucagon Antisera Production in 
Guinea Pigs 581 
Glucagon Bioactivity 45 7 
Calcium Levels 7 3 
- C-Terminal Antiserum 463 
Derivative (Methionine-27) 457 
Cjlucagon, Fragment 463 
Hyperinsulincmic Rats 661 
IR1 123 
-Like Immunoreactivity 19 
(GLI) 343 
Material 214 
Liver Cirrhosis 547 
Porcine 457 
Release 90 
Histamine and Histidine 100 







- Liver of ob/ob Mice 9 
Sulfonylureas and Metformin 332 
Glucoreceptors, Diabetics 261 
Glucose Absorption, G L I in Plasma 
343 
Anomer 214 
Infusion Test, Hypothyroid Dogs 
266 
Metabolism, Islet Transplantation 
200 
Nicotinamide 469 
Oxidation, Adipocytes 209 
Rat Adipocytes 498 
-6-Phosphate Dehydrogenase Effect 




Tolerance, Cimetidine 412 
Maximal Oxygen Uptake 424 
Transport, Adipocytes 209 
Rat Adipocytes 498 
Util ization, Insulin 270 
Glucuronides 275 
Glycerokinase 280 
Glycerol , Sulfonylureas and Metfor-
min 332 
Glycogen 11 8 
Liver and Muscle 675 
Glycoprotein, G H Receptor 616 
Glycogen Metabolism Muscle 255 
Synthesis, Cultured Muscle Cells 
207 
Glycopeptidcs 165 
Gonadotropin Receptors 61 
Release 389 
-Releasing Hormone 27 
Prolactin 5 38 
Clomiphene 478 
Dexamethasone 478 
Spinal Cord Damage 679 
Gonads. Cimetidine 220 
Goose, Feeding, Fasting. Oral 
Glucose 123 
Granulöse Cells (Rat) 181 
Graves' Disease, Raji Cell Test 622 
Growth Hormone 222, 362 
Fetal Rat Liver Enzymes 444 
Injection, Somatomedin 645 
lnsulin-Like Effects 136 
L-Tryptophan 149 
Pentobarbital and Urethane 
550 
Receptor, Rabbit Liver 616 
Release in Man, Insulin-
Induced, Calcitonin 641 
Reserve 664 
Secretion, Vincristine 692 
Somatostatin 147 
- Antiserum 550 
Sulfonylureas and Metformin 
332 
Guinea Pigs 606 
Gut, Entero-Endocrine Cells 589 




Heat Exposure, Plasma Hormone 
Levels 180 
Hcmodialysis 241 
- Hypermotilinemia 320 
Menstrual Disturbances 68 
Hepatic Enzymes, Anabolic Steroids 
489 
Hepatocarcinoma Cells 39 
Monkey 2 33 
Hexose Metabolism, Intracellular 
498 
High Density Lipoproteins, Oral 
Contraception 437 
High Insulin Responders 415 
Histamine. Glucagon and Insulin 
Release 100 




H P L C , Insulin Analysis 580 
5-HTP 90 
Human Chorionic Gonadotropin 
165 
Receptor Complex 61 
Hydrocortisone, CaBP 519 
11-Hydroxycorticosteroids 44 
Hyperammonemia, Insulin and Glu-
cagon Secretion 527 
Hyper- and Hypothyroidism, Lipo-
genesis, Liver 628 
Hypercalcemia 5 7, 577 
Hypercorticism I 30 
Hyperglycemia 669 
Somatostatin 643 
Hyperglycemic Laboratory Animals 
323 
Hyperinsulinism 669 




Chloride Phosphate Ratio 577 
Screening Test 577 
Hyperprolactinaemia 536 
Hyper secretion, Glucose-Independenl 
Insulin 432 
Hypertension, Essential 379 
Hyperthyroidism 222. 622 
Aminophyl l ine 190 
Fetal 362 
T4, T 3 . reverse T3 34 
Hypoaldosteronism, Sclective 47 
Hypo- and Hyperthyroidism. Lipogenesis, 
Liver 62 8 
Hypocaloric Diet 648 
Hypoglycaemia 44 
Asymptomatic reactive 252 
Enhancement by Propranolol 173 
Hypoglycemic Compounds 606 
Substances 606 
Hypoparathyroidism 375 
Hypophysectomiced Rats 136 
Hypophysectomy, Somatomedin 645 
Hypothalamic Hormones 27 
Hvpothvroid Infants, Gluconeogcnesis 
25 6 
Hypothyroidism, Dogs 266 
Hypothyroidism. Maternal 362 
Hypoxia , TSH Levels 155 
I 
Immune Complex, Circulating, Graves' 
Disease 622 
Immunogenicity, Glucagon 457 
Immunoreactive Growth Hormone Plasma 
and Urine 142 
Indomethacin, Glomerulopressin 513 
Prolactin Release 395 
- Sex Steroids 395 
Insulin 118, 289 
1 2 5 l - I n s u l i n 85 
Insulin Ac t ion , Adipocytes 209 
Adipocyte Metabolism 209 
Antagonism. Cultured Muscle Cells 
207 
Antibodies 187 
Calcium ATPase 698 
Levels 7 3 
(3-chain Fragment B21 26 498 
- Chromatography 580 
Degradation, Zucker Rats 525 
Effect on Adipose Tissue Enzymes 
694 
Mouse Liver Enzymes 14 
Extract ion, Liver 1 1 1 
l e t a l Rat Liver Enzymes 444 
Glucose and Ketone Body Utilization 
270 
Glycerokinase 280 
Highly Purified 455 
Hypoglycemia, Prolactin Response 319 
Induced Hypoglycaemia, C-Peptide 261 
- Injection-Adrenaline 561 
Free Fatty Acids 561 
Lactate 561 
Antagonism 207 
Levels, Liver Extraction III 
-Like Act ivi ty , Rat Adipocytes 498 
-Like Agents 209 
- Effects, Growth Hormone 136 
Pancreatitis 655 
Postprandial Response 253 
- Potentiating Activi ty Rat Adipocytes 
498 
XVI Subjcct Index 
Insulin, Pyruvat Dehydrogenase 285 
Rats 661 
Receptor, Zucker Rats 525 
Release 90 
Beta Cel l Membrane 104 
- Histamine and Histidine 100 
Nicotinamide 469 
Resistance 187 
Adipocytes, Fatty Acids 427 
- Liver Cirrhosis 547 
Response, Maximal Oxygen Up-
take 424 
- Secretion, Corticosterone 555 
- Enhancement by Somatosta-
tin Antiserum 23 
- Hyperammoniemia 527 
- in vitro 95 
Posthyperglyccmic 25 2 
- Vincristine 692 
Sensitivity, ü b e s e Mice 195 
- Serum Immunoreactive, Hypo-
thyroid Dogs 266 




Insulin, Total and Free 1 87 
Intestinal Bypass 648 
Loop , Dog 2 1 4 
Intraduodenal Carbohydrate Load, 
Exocrine Pancreas 346 
Iodine Intake 301 
Iodothyronine Metabolism 506 
I R I / I R G molar ratio 183 
Islets of Langerhans 100 
Corticosterone 555 
Transplantation, Intraportal 200 
Isolated Perfused Pancreas 95 
lsolated Islets, Insulin Secretion 23 
Juvenile Diabetics, Pancreatic A and 
B Cel l Reactivity 451 
K 
Kal ium, Progesterone 258 
Ketoacidosis 172, 270 
Diabetic, Treatment 338 
Ketogenesis 661 
Somatostatin 338 
Ketone Bodies, Somatostatin 338 
Metabolism, Muscle 1 
- Uti l izat ion, Insulin 270 
Ketot ic Diabetic Stupor 78 
K K mice 328 
Koletzky rat 329 
L 
Laboratory Animals 323 
Lactate, Insulin Secretion 95 
Sulfonylureas and Metformin 
332 
- Thyroxine Treatment 561 
Alanine 256 
L-Dopa, Prolactin 25 7 
Lean Littermates, Mice Thyro id 
Hormone Levels 37 
Lecithin/Sphingomyelin Ratio, 
Diabetic Pregnancy 612 




of TSH-Release 30 
( 3 H) Leucine Incorporation, Rat A d i -
pocytes 1 74 
Leucine-Induced Insulin Secretion 2 3 
Levodopa, 1 1-Hydroxycorticosteroids 
44 
Levonorgestrel 437 
Leydig Cells, Diabetic Rats 161 
L H , 68 
LH-Effect on Cyclic Nuclcotides in 
the Testis 573 
L H / F S H Responses, Lepromatous Le-
prosy 413 
L H Reccptors 181 
L H Release, Critical Period of 296 
- Nembutal 296 
Surge, Postovulatory Estrogen 481 
L H R H 358 
L H - R H Analogue 389, 391 
Dexamethasone 478 
- Serum Protein Binding 391 
Lipase Act iv i ty , Liver, Estrogen 531 
Lipase, Pancreatitis 655 
Lipidic Metabolism 503 
Lipids, Plasma Oral Contraception 
437 
Menstrual Cycle 696 
- Platelets 441 
Lipid Storage 158 
Lipogenesis, Hypo- and Hyper-
thyroidism 628 
Lipolysis, Adipocytes 209 
Lipoproteins 1 18 
Lipase 696 
Liver Cells, lsolated 366 
Cholesterol and Triglycerides 
503 
- Cirrhosis, Glucagon 547 
- Insulin resistance 547 
Enzymes, Effect of Insulin 14 
- Fetal Rat 444 
Gluconeogenesis 9 
Glycogen 675 
Insulin Extraction 1 1 1 
Membrane Adenylate Cyclase 
530 
- Perfusion 107 
Plasma Membrane, Rat 698 
Rabbit, Growth Hormone Recep-
tor 616 
Low-Insulin Responders 415 
L R H 68 
Spinal Cord Damage 679 
Luteinization 358 
M 
Magnesium, Adrenal Catecholamines 
404 
Progesterone 258 
Maturity-Onset Diabetes 77 
Sulfonylureas and Met-
formin 332 
Meal Frequcncy, Altered Meta-
bolie effects 524 
Medullary Carcinoma of Thyroid , 
Adrenal-Cortical Function 567 
Menstrual Cycle, Prolactin 5 34 
- Plasma Lipids 696 
Disturbances, Chronic Renal Fai-
lure 68 
Metabolie and Behavioral Differ-
ence 648 
Metabolie Consequences, Low Insulin 
Response 415 
- Effects, Altered Meal Frequency 524 
Metaproterenol 1 




Metoclopramide, Prolactin 5 37 
- Response 319 
Metyrapone 306 
Mineralocorticoid Hormones 379 
Mitochondrial Enzymes, Thyrotoxicosis 
304 
Mongolian gerbil 329 
Monkey 233 
Monoamino üx idase 606 
Morphology 655 
Mot i l in 320 
Mouse, Spermatogenesis 682 
Muscle Cells, Cultured 207 
Glycogen 675 
Metabolism 255 
Insulin Antagonism 207 
Ketone Body Metabolism 1 
Obesity 6 
- Rat Soleus, Thyrotoxicosis 304 
Myxedema, T 4 , T 3 reverse T 3 34 
N 
N a + Deprivation-Adrenal Catecholamine 
404 
NADPH-Enzymes , Leydig Cells 161 
Natrium, Progesterone 258 
N E F A 118 
Nembutal L H Release 296 
Neurones, lsolated 228 
New Zcaland Obese Mouse 328 
Nicotinamide, Glucose Metabolism and 
Insulin Release 469 
Nialamide 44 




Obesity, Enzymes of Energy Metabolism 6 
Obese "Fa t ty " Rats 646 
Females 382 
-Hyperglycemic Mice, Somatomedin 
528 
Mice, Insulin 195 
Mouse 329 
Rats, Insulin Resistance 427 
- Subjects, Reactive hypoglycemia 252 
ob/ob Mice, Gluconeogenesis 9 
- Thyroid Hormone Levels 37 
Octan-l-ol 255 
Oestrogen Treatment 664 
Oral Contraception, High Density Lipo-
proteins 437 
- Plasma Lipids 437 
Contraceptives, Folate Metabolism 64 
Ornithine Decarboxylase Activi ty 485 
Osteoporosis 516 
Vitamin D 3 1 68 
Osteotropic Hormones 83 
Osmolality, Plasma 241 
Osmoregulation, Prolactin 540 
Ovarian Blood Flow 513 
Ovary 485 
Subject Index X V I I 
Oxygen Uptake, Maximal, Glucose Tol-
erance and Insulin Response 424 
P 
Pancreas Perfusion, Corticosterone 
555 
Pancreatic Hormone Feed-back 123 
Pancreatitis, Acute 655 
Paraplegia 679 
Parathormone, see also Parathyrin 
Parathyrin Antisera 309 
- C- and N-Regional Fragments 309 
Parathyroid Hormone, Cadmium Up-
take 378 
Exercise 246 
- - R I A 375 
Parotid Secretion, Exercise Stress 
454 
P B B / L d Mouse 328 
Peptides, Serum 107 
Perfused Intestine, Glucagon-Like 
Immunoreactivity 19 
Perfused Pancreas 104 
Perfusion, Liver 9 
Perphenazine 100 
Phenformin 95 
Phenothiazine, Prolactin Release 395 





cal Function 567 
pH, Insulin Antibodies 187 
Phosphate Levels, Blood, 57 
Plasma 577 
Transport 519 
Phosphorus Depleted Rats 377 
Physical Exercise 675 
Pig, Exocrine Pancreas 346 
Pinealectomy, lsolated Islets 432 
Pineal lncubation Medium 432 
Pituitary, Effects of Cimetidine on 
220 
Platelet Lipids Contraceptives 441 
Postnatal Maturation, Rats 222 
Postprandial Insulin Response 25 3 
Potassium Excretion 275 
- Serum 47 
Prediabetcs, Low-Insulin Responders 
415 
Pregnancy, Diabetic, Amniot ic 
Fluid 612 
- Prolactin 5 34 
- Substance P 448 
Prepuberty 389 
Progesterone 181 
- Electrolyte Concentration 258 
Progestin. Plasma 358 
Proinsulin-Like Material 455 
Prolactin 68, 533 
Adrenal Function 540 
- Cimetidine 220. 257 
- Gonadotropine 5 38 
Heat Exposure 180 
L-Tryptophan 149 
- Metoclopramide 5 37 
Nonresponsiveness to Arginine 
in Diabetes Mellitus 583 
Osmoregulation 540 
Prolactin Producing Adenoma, Dop-
amin, Bromocriptine, T R H 452 
- Puerperal infertility 5 36 
Release, Indomethacin 395 
Phenothiazine 395 
Response to T R H , Metocloprami-
de and Hypoglycemia 319 
- Secretion, Cimetidine 412 
Propranolol 34, 52 
- Conversion of T 4 to T 3 366 
- Hypopglycemia 173 
Propylthiouracil 39 
Prostaglandins, A C T H Effect 585 
Prostaglandin E ] , Fat Cells 176 
Prostatic Carcinoma 635 
- Hyperplasia, Benign 635 
Protamine- 1 2 51-Insulin 85 
Protein Biosynthesis, Streptozoto-
cin Diabetic Rats 107 
- Synthesis In Vi t ro , Exocrine 
Pancreas 352 
- Synthesis, Muscle 289 
- Plasma 107 
- Synthesis, Rat Aorta 384 
Proteohormone Receptors 60 
Pyruvate Dehydrogenase, Fat Cells 
285 





Radioreceptor Assay, Somatostatin 
216 
Raji Cel l Test, Thyroid Antibodies 
622 
Rat Hemipituitarics, TSH-Release 30 
Rats 222 
Receptor üver lap , FSH-TSH 689 
Receptors, Human Chorionic Gona-
dotropin 60 
Relaxin, Collagen Metabolism 408 
Cyc l ic A M P 408 
Renal Changes Diabetes 200 
Compensatory Hypertrophy 669 
- Failure, Chronic, Moti l in 320 
- Changes, Regression Rate of 200 
Insufficiency, Chronic, Antidiure-
tic Hormone 241 
Renin 371 
-Act ivi ty , Night-Day Variations 
570 
Primary Aldosteronism 570 
- -Substrate 371 
Retina, Somatostatin 79 
Reverse T 3 34 
reverse T 3 506 
Reverse Triiodothyronine, Fetal 
Sheep 509 
Ribosomal Profiles, Muscle 289 
S 
Salt Intake, Hypertension 379 
Sand rat 327 
Secretin. Pancreatitis 655 
Seromucoid 107 
Serotonin 149 
Sertoli Cell Cultures 80 
Serum Insulin, Hyperthyroidism 190 
- Protein B i n d i n g - L H - R H 391 
Sex Difference, Prolactin 534 
"Sex Reversed" Factor 682 
Sex Steroids, Indomethacine 395 
Phenothiazine 395 
Sheep, Pregnant and Foetal 237 
Shift-Effect 666 
Silicone 255 
Sodium Dichloroacetate 95 
- Obesity 382 
- Reabsorption 275 
Solanum Glaucophyl lum 5 7 
Somatomedin 645 
- Act iv i ty Obese-Hyperglycemic Mice 
528 
- Circadian Variations 586 
- Diabetes 216 
- (Sulfation Factor) 472 
Somatostatin 2 3 
- Antidiuret ic Hormone Secretion 177 
- Antiserum 550 
Insulin Secretion 23 
- Fetal Brain Cells 147 
Hyperglycemia in Man 643 
- -Like Immunoreactivity, A l loxan 457 
Liver Cirrhosis 547 
- Pentobarbital and Urethane 550 
- Plasma 457 
Rat Retina 79 
Thyro id 184 
- Treatment 655 
Diabetic Ketoacidosis 338 
Spermatogenesis 682 
Sperminc 209 
Sphingomyelin, Diabetic Pregnancy 612 
Spiny mouse 324 
Starvation 669 
Stereospecificity G H Receptor 616 
Streptozotocin Diabetes 107, 200, 661 
Diabetic Rats 172 
Substance P. Pregnancy 448 
- Various Clinical Disorders 448 
Sucrose Diet I 1 8 
Sulfation Factor (Somatomedin; 472 
Sulfonylurca 104 
Sulphonylureas, Combined with Met-
formin 3 32 
Surgerv, Insulin and Glucagon Response 
488 
Sympathetic Nervous System 379 
System, Diabetes 493 
T 
Testicular Func t ion , Spinal Cord 
Damage 679 
- Receptors 165 
Testis, Hormone Receptors 689 
lncubation in Vi t ro 573 
Testosterone Effect Cycl ic Nucleotides in 
the Testis 573 
Thiamine Pyrophosphatase 697 
Pyrophosphate 95 
Thymus, Liver 503 
Thyro id Auto-antibodies, Graves' Disease 
622 
Raji Cel l Test 622 
- Cimetidine 220 
- Gland, Relationship to Adrenal Cor-
tex 666 
XVIII Subject Index 
Thyroid Hormone Levels, Obese-
Hyperglycemic Syndrome 37 
Metabolism 39 
Production, Human Thyro-





Receptors (Human) Thyroid 
Hormone Production 399 
Thyroxine 222 
Analogs, Metabolism of 233 
Conversion of 366 
- Fetal Rat Liver Enzymes 444 
Fetal Sheep 509 
Thyroxine, Glycogen 675 
Iodine Intake 301 
Treatment, Metabolie Response 
to Insulin Injection 561 
Uptake and Metabolism 228 
Total Ketone Bodies. Sulfonylureas 
Metformin 332 
Translation, Protein Synthesis in 
Muscle 289 
Transplantation, Islets 200 
Kidney 68 
TRH, Luteotrophic Activi ty 358 
Prolactin Response 319 
Stimulation, TSH Dynamics 293 
Triglycerides 1 1 8 
Diurnal Pattern 25 3 
Liver 503 
Triiodothyronine 366 
Fetal Sheep 509 
Glycogen 675 
Iodine Intake 301 
Triton X-100 Extracts, Liver 
Plasma Membrane 698 
Tryptophan 149 
T S H , Blood Acute Hypoxia 155 
Dynamics atter T R H 293 
Producing Adcnoma, TRH, Dopa-
min, Bromocriptine 452 




Turner's Syndrome 664 
U 
Urethane, Growth Hormone 
Release 550 " 
Somatostatin Release 550 
Urine Immunoreactive Growth 
Hormone 142 
Upright Posture, Serum Potassium 
47 
V 
Vascular Smooth Muscle 384 
Vasopressin, Chronic Renal 
Failure 241 
Vincristine, Insulin and Growth 
Hormone Secretion 692 
Vitamin D2 184 
Vitamin D 3 377, 5 1 9 
CaBP 519 
l , 2 5 ( O H ) 2 168 
Osteoporosis 168 
W 
Water Intake 1 30 
Weight Loss 648 
Y 
Yellow obese mouse 328 
Z 
Zinc Ions, Adenylate Cyclase 530 
Zucker rat 329, 525 
309 
Horm. Metab. Res. 11 (1979) 309 -317 
Tests on Three Antisera and Subsequent Development of Radioimmunoassay for 
Different Regions of Human Parathyrin 
W.G. Wood, I. Marschner and P.C. Scriba 
Laboratorien für Klinische Chemie und Endokrinologie, Medizinische Klinik Innenstadt der Universität 
München, Germany 
Summary 
Three antisera (Ab), two raised in sheep and one in a goat, 
with determinants for different parts of the human para-
thyrin (hPTH) molecule have been tested. One sheep antibody 
(Ab S-469 VI ) recognised only C-regional fragments of hPTH 
(C-hPTH), the other (AbS-478 VI) both C- and N-regional 
fragments (C+N+hPTH), whilst the goat antibody, raised 
against 1-34 hPTH (Ciba) was specific for N-regional frag-
ments (N-hPTH). Kinetic studies showed that the differing 
affinities of A b S-469 V I and A b S-478 V I antibodies for 
bovine P T H (bPTH) and C-hPTH made it possible to develop 
sensitive assays giving results in as little as 8 hr after receipt 
of blood, and a routine assay giving results within 30 hr. A l -
though the numerical P T H levels from the assay were differ-
ent, their ability to distinguish between normals and patients 
with hyperparathyrinemia (HPT) was similar. Studies on the 
labelling and Separation of 1 2 S I - b P T H led to a tracer with a 
shelf life exceeding 3 months. Correlation between assays us-
ing A b S-469 and A b S-478 was good, although exceptions 
occurred, which may have been due to the differing specifi-
city of the antisera. 
Comparison of the original 7-day assay with the 24 hr assay 
using A b S-469 V I in 109 patients gave a correlation coeffi-
cient r = 0.957, and using A b S-478 in the 24 hr assay in 81 
patients a correlation coefficient r = 0.934. The results in the 
24 hr assay with A b S-469 V I were 3 times higher and those 
from the 24 hr assay with A b S-478 V I 20% higher than in 
the 7 day assay. The normal ranges in the 7 day and both 
24 hr assays were also different. 
The clinical value of the N-hPTH assay has not been fully es-
tablished but is useful in explaining some anomalous results 
obtained in the C- and C+N-hPTH assays, in which the non-
biologically active P T H fragments were within the normal 
ränge for the assay, but in which the N-hPTH level, i.e. the 
biologically active part of the P T H molecule, was significant-
ly elevated. 
Key-Words: Human Parathyrin Antisera - RIA - C-Regional 
Fragments - N-Regional Fragments - C- and N-Regional 
Fragments 
Introduction 
The main disadvantage of many published P T H assays 
is the long incubation time required (Arnaud, Tsao 
and Littledike \91\;Berson and Yalow 1963;Maltet 
and Brunelle 1975; Almquist, Hjern and Wästhed 
1975; Sinha, Queener and DeMoor 197'5; Hehrmann, 
Wilke, Nordmeyer and Hesch 1976). This study was 
undertaken to examine the possibility of assay for 
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C-hPTH, C+N-hPTH and N-hPTH which would give 
results in the minimum time without endangering 
their clinical value. The introduction of a "same-day-
results" assay was envisaged only to help clinicians 
in emergency cases in which HPT was suspected and 
such an assay, when combined with an angiographic 
study of the thyroid region would assist in localizing 
an adenoma i f present, thus helping the surgeon. 
As the antisera were raised against undefined prepara-
tions of non-human P T H in the case of S-469 V I and 
S-478 V I , studies were made with human and bovine 
P T H to characterise the binding kinetics for these as-
says. 
Materials and Methods 
1) Antibodies used 
A b S-469 with C-regional acitvity and S-478 VI with C+N-
regional activity were raised in sheep against a mixture of 
b P T H and p P T H and have been described in detail elsewhere 
(Hehrmann, Wilke, Nordmeyer and Hesch 1976; Hehrmann, 
Nordmeyer, Wilke and Hesch 1977). Both were obtained 
from Dr. R. Hehrmann and Prof. R.D. Hesch in Hannover. 
Ab-"P inkey" was raised in a goat against the 1-34 h P T H 
synthetic peptidc from Ciba, Basel, Switzcrland, and was 
obtained from the European Parathyroid Study Group 
(EPSG) via Prof. R. Ziegler in Ulm, Germany. 
A l l A b were diluted with 0.05 M Barbital Buffer, p H 7.5 
containing 1% human serum albumin and 12.5 Antiplasmin 
Units (APU) of Aprotenin/ml (Trasylol®-Bayer or Antago-
san®-Behringwerke) (Buffer 2). 
2) Standards and Tracers 
bPTH (Inolex, Chicago) was used as Standard (Lot No . 1508 
B 002) and for labelling (Lot . No. 1515 A 001). A further 
lot (Lot. No . 1515 B 001) proved to be unsuitable for tra-
cer preparation, due to a high unspecific binding. Standard 
and tracer for the N-regional assay was prepared from the 
1-34 hPTH synthetic peptide from Ciba. 
"C-hPTH Standards" consisted of serial serum dilutions from 
a patient with a secondary HPT calibrated against the S-469 
50Q assay described below. A l l Standard curves were made 
up in PTH-free serum (PTHFS) obtained from a parathyroid-
ectomised patient. 
Tracer was prepared by a modification of the method describ-
ed by Greenwood et al. (Wood and Marschner 1978). 
Desalting of the tracer was carried out at room temperature 
a Sephadex G-10 column and further purification was carried 
out at 4 °C on Ultragel ( L K B ) AcA-54 (Wood, Marschner and 
Scriba 1978). 
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Table 1 Main characteristics of 7 assays described 
Assay 
Characteristic S-469 50 C L S-469 50 L S-469 50Q S-478 90Q S-469 50SQ S-478 90SQ N-90Q 
Antibody initial 
dilution 1: 20,000 20,000 14,000 2,400 14,000 2,400 25,000 
Serum volume ßl 50 50 50 90 50 90 90 
lncubation time 
pre- + tracer- 96 + 72 96 + 72 18 + 6 18 + 6 0 + 6 0 + 6 18 + 6 
incubation hr. 
Tracer Bq/tube 50 170 330 330 500 500 330 
lOO.Bo/T 30 -35 3 0 -3 5 1 5 - 2 0 1 5 - 2 0 1 2 - 1 7 1 2 - 1 7 5 5 - 6 5 
Normal ränge 
ng eq/ml < 0 .28-0 .5 < 0 .28-0 .5 < 0 .66-1 .5 < 0 .24-1 .0 
+. . + . < 0 .05- C.15 
Standard curve 0.19-12.5 0.19-12.5 0 .19-12.5 0.19-12.5 • ^ O - i s - i o - o ++0.15-10.0 +++0.07 - 1 0 . 0 
+ Not determined •"ng eq hPTH/ml V / m l l _ 3 4 hPTH 
The fractions from the A c A 54 column with the highest maxi-
mum binding ( B u ) and lowest unspecific binding (N) were di-
luted to give about 10 K B q / m l , with Buffer 2. These tracer So-
lutions had a useable shelf-life of more than three months; 
rather longer than the 9 days reported elsewhere (Almquist, 
Hjern and Wästhed 1975). 
The elution pattern from the AcA-54 column was stable, the 
Variation of the position of the immunoreactive peak being 
over a 12 month period 183 + 3.0 ml , using the same col-
umn (n = 18 column-runs). 
3) Assay Systems 
aj Assay Codes 
The following code System is used in the rest of this paper. 
Each assay consisted of a 3-part code. The first letter and 
numbcr denoted the antiserum used e.g. S-469 xxx , the sec-
ond figure the volume o f serum used e.g. S-469 50x and the 
final letter(s) the Separation method and length of assay, C 
for charcoal Separation, L . for 7 day assay Q for 24hr-assay 
and SQ for same-day-assay. The latter 3 assays all used Poly-
ethylene glycol for Separation of bound free hormone. As 
an example S-478 90Q - assay with A b S-478, 90 ß\ serum 
separated with Polyethylene glycol and having a 24 hr total 
incubation. 
b) Original Assay - S-469 50 CL (Table 1) 
This was the original assay in routine use. 50 ßl serum and 
200 ß\ A b were preincubated for 4 days at 4 °C. 1000 ßl 
dextran charcoal (2.5 g Dextran T-70 (Pharmacia) + 25 g No-
rit-A (Sigma) in 1000 ml Buffer 2) was added, and after cen-
trifugation (2500 g, 15 min) the supernatant transferred to 
a clean tube and counted for 5 min in a gamma-counter. The 
results in this and all subsequent assays were then worked 
out using a spline function (Marschner, Erhardt and Scriba 
1975; Marschner, Dobry, Erhardt, Landersdorf er, Popp, Rin-
gel and Scriba 1974) and off-line techniques by Computer 
(Siemens 404/3). The ränge of the Standard curve was 0.19 
-12 .5 ng bPTH/ml , Bn was measured 10 times and the Stan-
dard curve points and sera 5 times. 
c) Modified Long Assay - S-469 SQL (Table 1) 
The assay was identical with S-469 50CL but more radioac-
tive tracer was added to each tube and Polyethylene glycol 
(PEG) (12% Solution in 0.18 M NaCl) was used to separate 
the bound and free hormone. The resulting precipitate was 
counted for two min. 
dj Quick Assay - S-469 50Q, S-478 50Q and S-478 90Q 
(Table 1) 
These assays all had a preincubation of 1 8 hr and after addi-
tion of tracer, a second 6 Irr incubation before Separation 
with P E G and counting. 
e) Same-day Assays - S-46950SQ and S-478 90SQ (Table 1) 
These assays only had one incubation Step where A b , tracer 
and serum were incubated together at 4 °C for 6 hr. On ly a 
C-hPTH Standard curve could be used due to the binding k i -
netics of the A b with b P T H and C-hPTH (see below for re-
sults of the kinetic studies). Other details were the same as 
for the Quick assays. 
f) N-regional Assay - N-90Q (Table 1) 
The details for this assay are identical with those for the S-
478 90Q assay except that the Standard curve used the 1-34 
hPTH Ciba peptide. 
In all assays using P E G Separation, 100 ßl carricr serum was 
added to each tube directly before the P E G in Order to 
smooth-out the unspecific binding in each serum. 
4) Kinetic Studies 
Kinetic studies were carried out with S-469 V I and S-478 VI 
to investigate the different affinity to bPTH and C - h P T H w i t h 
time. Bn, bovine Standards of 1 and 3 ng/ml and human sera 
with 1 and 3 ng/ml (measured by the S-469 50L assay) were 
used in this study. Bovine Standards were made up in P T H F S . 
The kinetics were studied with and without a preincubation 
of 18 hr before tracer addition and were carried out over a 
7 or 10 day period. 
5) Establishment of Normal Range and Correlation Studies 
Normal ranges were obtained for the following 4 assays: S-
469 50L, S-469 50Q, S-478 90Q and N-90. Correlations 
were made between the first three, and their ability to dif-
ferentiate between normal collective and patients with HPT 
tested. The stability of binding of tracer at each point on 
the Standard curve was tested for each of the above assay as 
well as for S-469 50L. In these studies no correction was 
made for the age of the tracer which was from 1 to 110 
days old. 
Results 
1) Tracer Preparation 
a) 1 2 5 l - b P T H 
Figure l a shows the elution-profils of the iodination 
mixture desalted on a Sephadex G-10 column. Here 
the proteimiodide count-ratio was usually between 
3:1 and 4 :1 . 
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Fig. l b Further purification of the protein peak from l a 
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Fig. l a Elu t ion profile of Sephadex G-10 column using buf-
fer 2 as eluant. Fractions contained 500 ßl. The protein peak 
eluted with the void volume 
Only the first of the two closely separated peaks has 
any immunoreactivity. The B 0 o f the material from 
the first major peak (Peak 3) was 52% in this exam-
ple and in the second peak (Peak 4) only 5%. The 
unspecific binding was under 3% in both cases. Peak 
4 showed no immunoreactivity with the "P inkey" Ab 
thus ruling out an N-regional peptide. The tracer so 
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Fig. 2a Correlation between S-469 50L and S-469 50Q as-
says in 109 patients 
decrease in B 0 was under 3% as was the increase in 
N . The quantity and quality of the tracer appears to 
be greater than reported elsewhere (Hehrmann, Wilke, 
Nordmeyer and Hesch 1976). 
b) 1 2 s 1-1 -34 h P T H 
The elution profile of the iodinated 1-34-hPTH on 
the Sephadex G-10 desalting column was similar to 
Fig. l a . The iodide:protein count-ratio was normal-
ly between 1:1 and 1.5 : 1. The rechromatography 
on Ultrogel AcA-54 gave a damage-peak at the void 
volume and a Single immunoreactive peak appearing 
at approximately the same place as human calcitonin 
and ß-endorphine indicating an iodinated monomeric 
form of the peptide. 
2) Assays 
a) Characteristics 
The results given by the S-469 50CL and S-469 50L 
assays were the same, but the addition of higher tra-
cer amounts abolished the "hook-effect" (Joel, Schön-
berg, Ilg and Keller 1974) often seen in the S-469 50-
C L assay. Addi t ion of tracer in excess o f 350 Bq/tube 
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Table 2 Results of an angiographic study measured in 7 assay Systems of a patient with 2.HPT. Control sera show the 
Variation in the absolute values in the different assay Systems 
Assay 
S-469 50 L S-469 50Q S-469 50SQ S-478 50Q S-478 90Q S-478 90SQ N-90Q 
Control Sera ng eq/ml ng/ml 
R K S 1771 0.41 1.11 0.12 0.27 0.21 0.17 _ _ 
R K S 1772 0.79 1.94 0.40 0.66 0.55 0.53 
R K S 1773 3.04 7.83 4.25 4.33 3.35 4.80 
Angiography Patient Bo 
r. int. jug. vcin upper 0.90 2.12 0.45 1.54 1.27 1.28 0.06 
1. int. jug. vein upper 0.95 2.20 1.00 1.67 1.38 1.21 0.05 
r. int. jug. vein lower 0.75 2.22 0.82 1.86 1.42 1.46 0.09 
1. int. jug. vein lower 1.05 2.28 0.95 1.58 1.26 1.39 0.11 
thyroid ima vein 4.89 7.97 3.02 6.92 5.98 5.24 0.29 
int. thyroid vein 4.05 7.90 2.13 6.00 5.95 4.32 0.28 
1. subclavian vein 1.16 2.11 0.91 1.67 1.42 161 0.12 
(freshly labelled tracer) caused little increase in B 0 
but significantly increased the unspecific binding, 
thus flattening the Standard curve, seen in the in-
creasing value of the 50% intercept. The ränge cover-
ed by the Standard curve was the same for both S-
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Fig. 2b Correlation between S-478 90Q and S-478 50L as-
say in 81 patients 
creased precision thus making it possible to set up 
the sera in triplicate instead of in pentuplicate as in 
S-469 50CL. In all patients who had disproteinemia 
an unspecific binding was necessary to correct the 
bound counts. In effect, this was seen in about 10% 
of all patients. 
The values from the S-469 50Q assay were 3 times 
higher than those from the S-469 50L assay. This 
effect was seen throughout the concentration ränge. 
Fig. 2a shows the correlation between these two as-
says on 109 patients. The S-478 50Q assay was soon 
abandoned for the S-478 90Q assay as the latter gave 
better precision. The values from the S-478 90Q as-
say were around 20% higher than those from the S-
469 50L assay (Fig. 2b). The correlation between 
these assays was highly significant. The results used 
in the correlation studies were taken from parallel 
assays set up at the same time, 3 or 4 such assays 
being used in the construction of Figures 2a and 2b. 
The same-day assay S-469 50SQ and S 4 7 8 90SQ 
were developed for emergency use. The characteris-
tics of the 4 main assays are shown in Table 1. 
b) Diagnostic Use 
Table 2 shows the results in 7 assays of an angiogra-
phic study of a patient with suspected secondary 
H P T , together with values from precision control 
sera. The clinical value of the results is the same in 
all cases. Although the numerical values are often 
very different. 
The N-regional assay was performed routinely on 
over 300 samples which came into the laboratory 
for " h P T H " assay to assess its clinical usefulness. 
Certain patients were found who had normal or on-
ly slightly elevated parathyrin levels when assayed 
in the S 4 6 9 50L or S-478 90Q assays, but who had 
definite clinical signs of HPT . Many of these patients 
showed an elevated N-90Q assay value between 3 and 
Antisera and R I A for Human Parathyrin 
Fig. 3 Patient 0 - 2 2 showing immunoreactive 
P T H serum levels before and up to 3 days after 
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10 times the normal values. One patient was found 
to have an adenoma which secreted N-regional im-
munoreactive P T H and Figure 3 shows the levels of 
P T H measured in three assays before and up to 3 
days after removal of the adenoma. 
To assess the usefulness o f the assays in their ability 
to differentiate between a normal population and 
patients wi th HPT, parallel studies were made be-
tween the S-469 50L and S-469 50Q assays in 76 
patients (Fig. 4a) and between S-469 50L and S-
478 90Q assays in a further 90 patients (Fig. 4b). 
The results showed that the assays have the ability 
to differentiate between normals and HPT and also 
between patients with calcium metabolism disorders 
due to other causes and HPT. 
3) Standard Curve Characteristics and Reproducibility 
Table 3 shows the Standard curve binding characteris-
tics o f the S-469 50L, S-469 5 0 C L , S 4 6 9 50Q and 
S-478 90Q assays, together with sensitivity and 50% 
intercept values for each assay. Table 4 shows the 
same for the N-90Q assay. The reproducibility o f 
binding is seen, and no correction has been made for 
the age of tracer. The change from charcoal to P E G 
for Separation of bound and free hormone has mini-
mal effect on the binding but has a lower Standard 
deviation. 
The S-469 50Q assay was less sensitive and had a 
higher 50% intercept but when seen in context with 
the 3 times higher results, the assay was comparable 
to the S-469 50 L assay. The binding characteristics 
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Fig. 4b Comparison of results between S-478 90Q and S 
S-469 50Q assays in 47 normal persons and 76 patients with 469 50L assays in 48 normal persons and 90 patients with 
calcium metabolism disturbances calcium metabolism disorders 
314 W.G. Wood, I. Marschner and P.C. Scriba 
Table 3 Mean and Standard deviation (s.d.) of the percent binding of the Standard curve points, together with the sen-
sitivity, 50% intercept and number of assays from which the data was obtained 
Standard 
S-469 5 0 C L 
%Bo 






ng b P T H / m l X s.d. C V % X s.d. C V % X s.d. C V % X s.d. C V % 
0.19 96.3 ± 1.74 1.82 97.2 + 1.84 1.89 98.0 + 0.62 0.64 93.7 + 2.89 3.09 
0.39 90.9 ± 1.78 1.95 92.4 ± 2.06 2.23 96.1 + 1.23 1.28 88.5 ± 3.29 3.72 
0.78 82.9 ± 3.94 4.70 84.6 ± 3.67 3.67 92.8 ± 2.00 2.16 78.2 ± 4.33 5.55 
1.56 67.5 ± 6.19 9.16 68.1 + 2.76 4.06 83.2 ± 2.28 2.75 63.0 ± 5.48 8.69 
3.12 39.1 ± 6.67 17.1 40.8 ± 4.28 10.5 65.0 ± 4.62 7.11 44.6 ± 4.68 10.4 
6.25 15.6 ± 2.87 18.4 18.2 ± 2.41 18.2 36.9 ± 1.08 2.93 26.9 ± 4.97 18.4 
12.5 9.0 ± 1.17 13.0 11.4 ± 1.66 14.6 16.1 ± 2.28 14.2 16.5 + 4.10 24.8 
Sensitivity 
ng b P T H / m l 
50% intercept 
ng b P T H / m l 













Table 4 This shows the same data as Table 3, but for the 
N-90Q assay 
Standard Bo% C V % 
ng l - 3 4 h P T H / m l x s.d. 
0.15 81.1 ± 2.13 2.56 
0.31 65.8 + 3.10 4.71 
0.62 47.6 + 3,29 6.92 
1.25 30.3 ± 3.20 10.6 
2.50 18.0 ± 4.30 23.8 
5.00 12.2 + 3.82 31.2 
10.0 8.3 ± 3.50 42.0 
Values from 8 assays 
of the S-478 90Q assay were slightly different al-
though sensitivity and 50% intercept were similar 
to S-469 50CL and S-469 50L assays. The curve 
was not so steep in the S-478 90Q assay but feil 
away from zero quicker. The N-90Q assay was more 
sensitive and was able to measure within the normal 
ränge, the sensitivity and 50% intercept being about 
20% of those for the S 4 7 8 90Q assay. As the normal 
ränge o f this assay was also about 20% of that o f S-
478 90Q, the two were comparable in this respect. 
In all cases, sensitivity was defined as the point of 
the Standard curve lying 3 Standard deviations away 
from the zero Standard. A l l values are the mean and 
Standard deviation of several assays as shown. 
4) Kinetic Studies 
The kinetic study results are shown in Figures 5a and 
5b and highlight the different binding characteristics 
of S-469 VI for b P T H and C-hPTH. Figure 5a shows 
the rate of binding o f tracer after a 18 hr preincuba-
tion expressed as cpm bound. 
Table 5b shows the rates of binding when the prein-
cubation is omitted. The results show quite clearly 
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Fig. 5a A b S-469 kinetic studies showing the dif-
ference in the reaction rates of bPTH and hPTH 
with time, accounting for the difference in results 
obtained in the long and short assays. Assay v i th 
18 hr pre-incubation 
Antisera and R I A for Human Parathyrin 31 5 
Fig. 5b As Fig. 5a but without the 18 hr pre-
incubation. This shows why the same day assay 
only functions with an hPTH Standard curve 
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the S-469 50L assay, and also why the same-day 
assay only function with a C-hPTH Standard curve. 
The kinetics for S-478 VI were similar and have 
been reported elsewhere (Wood, Marschner and 
Scriba 1978). 
Discussion 
This study has demonstrated that a modification o f 
the labelling technique combined with drastic short-
ening of the assay time has led to assays with the 
same sensitivity and reproducibility as the original 
long assays. In the tracer preparation, no trace of 
„ d a m a g e " peaks was seen in the elution profiles as 
reported elsewhere (Hehrmann, Wilke, Nordmeyer 
and Hesch 1976) which lead to the question as to 
whether these are artefacts introduced by the tech-
nique used, rather than oxidation products produc-
ed by the chloramine-T. The Ultrogel A c A 54 col-
umn only functioned at 4 °C. 
This labelling technique in producing "long-life" tra-
cer is not only restricted to bPTH but is used regu-
larly in this laboratory in the production and stor-
age of human calcitonin (shelf-life longer than six 
months) transferrin and /3-endorphine. 
The introduction of an analogue of the Wide tech-
nique (Wide, Nillius, Gemzell and Roos 1973) led 
to the shortening of the assay without any loss of 
sensitivity or clinical value of the results. Ab S-469 
VI was "serum sensitive" and any attempt to in-
crease the serum amount in the assay led to reduc-
tion of B 0 and to a less sensitive assay. This to-
gether with the difference in reaction rates be-
tween b P T H and C-hPTH with the antibodies rais-
ed in sheep have no doubt helped in the develop-
ment of such short assays, especially the same-day 
assays. The circulating forms of hPTH are themselves 
undeftned, and are composed of peptides of varying 
compositions and biological activity (Berson and Ya-
low 1968; Habener, Powell, Murray, Mayer and Potts 
jr. 1971; Segre, Habener, Powell, Tregear and Potts jr. 
1972; Canterbury and Reiss 1972; Canterbury, Levey 
mdReiss \913\Arnaud, Goldsmith, Sizemore, Oldham, 
Bischott, Larsen and Gilkinson 1973; Arnaud 1974; 
Silverman and Yalow 1973). In certain pathological 
conditions the intact 1-84 hPTH is present in serum 
in relatively small amounts when compared with the 
degradation products (Segre, Niall, Habener and Potts 
jr. 1974; Purnell, Scholz, Smith, Sizemore, Black, 
Goldsmith and Arnaud 1974; Segre, D'Amour and 
Potts jr. 1976). Bearing these facts in mind, the val-
ue of a 1-84 h P T H assay can only be supplementary 
to the fragment assays at present in use. More impor-
tant is the introduction of internationally defined 
preparations extracted from human serum or para-
thyroid adenomas containing C- and N-regional pep-
tides to act as reference Standards in addition to 
those already axisting for 1—84 h P T H such as the 
M R C 75/549 . 
A b S-469 VI does not react with 1-34 h P T H and A b 
S-478 V I only to give a B 0 of 5 -10% in the S-478 
90Q assay using 1 2 S I-labelled 1 - 3 4 hPTH as tracer. 
The 1 2 S I - b P T H from Inolex does not react with the 
"Pinkey" Ab even at an i .d. o f 1:10,000 showing 
that this material is unlikely to be 1-84 b P T H , but 
more likely a large C-regional peptide or group of 
peptides. Results from other laboratories (Hehrmann, 
Wilke, Nordmeyer and Hesch 1976) have shown that 
S-469 VI does not react with the 13-34, 18-34 and 
23-34 peptides o f h P T H , or with the 1-34 hPTH 
from Beckman. Another Observation v/as that the 
same-day assay coded S-478 90SQ did not give use-
able results i f the incubation was carried out at 
room temperature instead of at 4 °C. 
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The reason for the higher values obtained in the 
shorter assays for the C- and C+N-regional assays 
may be due to the fact that the antibodies wi th 
the highest avidity for C-hPTH bind first, and the 
less avid ones bind the bPTH somewhat more slow-
ly eventually giving rise to more counts bound, 
hence to lower results. In contrast, the values in a 
4 hr Version of the N-90Q assay were identical wi th 
the 24 hr assay, possibly due to the fact the anti-
body was raised against a human peptide o f unique 
structure, rather than a undefined mixture of b P T H 
and p P T H of unknown structure and purity. The k i -
netic studies have shown the reason for the differ-
ent numerical values for P T H with different incuba-
tion times. In patients at risk the short assay were 
combined with an angiographic study in order to 
locate the areas of high P T H production. It has been 
clearly demonstrated in this laboratory that the C-
and C+N-regional assays may be just as good as an 
N-regional one in most cases for these purposes, as 
shown in Table 2 and the other angiographic studies 
carried out. The C-assays may be better because of 
the much larger concentration differences between 
"background" and "hot" areas. 
The use of parathyrin-free serum (PTHFS) for Stan-
dard curves is imperative in all non-extractive proce-
dures in order to standardise conditions in the Stan-
dards and serum samples under test. The use of syn-
thetic protein Solutions such as albumin or a "synthe-
tic serum" made up of 4% H S A , 1% ß-globulins and 
2% human 7-globulins was not acceptable as the B 0 
and shape of the Standard curve were different from 
that obtained using P T H F S . Equine serum and serum 
from H P X dogs were also unsuitable for the same 
reason. The disadvantage of P E G is in its serum glo-
bulin concentration dependance but the small num-
ber o f patients with disproteinemia severe enough to 
cause false results was so low as not to cause undue 
hinderance with excessive numbers of unspecific bind-
ing tubes - about 10% of all samples received. Un-
specific binding tubes should be run with all sera 
from dialysis patients, as this group has shown the 
greatest deviation in unspecific binding, which could 
significantly affect results i f not taken into account. 
A l l sera wi th total protein outside the ränge 6 0 - 8 0 
g/liter should be run with an unspecific binding. 
The N-regional assay showed values within and above 
the normal ränge in several patients with cl inically 
confirmed HPT, as has been reported elsewhere (Min-
ne, Raptis and Ziegler 1976), and was therefore only 
used in cases where the other assays had given un-
clear results. 
Tables 3 and 4 have shown that the assays are sensi-
tive and reproducible enough for routine use. The 
S-478 90Q assay was adapted for routine use because 
of its wider specificity and also as a result o f a meet-
ing of PTH-laboratories in Hannover, Germany, in May 
1976 (Chairman Prof. R.D. Hesch). This assay has de-
detected all 2. HPT and between 85 -90%. l . H P T pa-
tients in the 12 months that this assay has been in 
routine use and in which time over 1800 patients 
have been examined. 
To conclude, although the assays here described are 
heterologous, the results which they give allow a ra-
pid and reproducible assay for hPTH to be perform-
ed with the accuracy required in the confirmation or 
rejection of hyperparathyrinaemia. 
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